Query 019922
Match_columns 334
No_of_seqs 212 out of 2009
Neff 9.9
Searched_HMMs 46136
Date Fri Mar 29 05:36:19 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/019922.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/019922hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0534 NorM Na+-driven multid 100.0 1.3E-39 2.8E-44 303.5 34.9 285 47-334 12-301 (455)
2 PRK10367 DNA-damage-inducible 100.0 2.2E-36 4.8E-41 281.6 36.0 284 48-334 5-292 (441)
3 PRK00187 multidrug efflux prot 100.0 5.9E-36 1.3E-40 280.9 36.1 285 46-333 4-295 (464)
4 PRK10189 MATE family multidrug 100.0 6.9E-35 1.5E-39 274.0 37.0 283 49-334 26-319 (478)
5 PRK09575 vmrA multidrug efflux 100.0 4.7E-34 1E-38 267.6 34.4 285 48-334 8-295 (453)
6 PRK01766 multidrug efflux prot 100.0 9.3E-33 2E-37 259.5 35.5 285 46-333 6-298 (456)
7 TIGR00797 matE putative efflux 100.0 2.4E-28 5.1E-33 221.3 34.1 271 60-333 1-275 (342)
8 KOG1347 Uncharacterized membra 100.0 9.7E-28 2.1E-32 222.6 29.4 288 46-334 22-309 (473)
9 PRK00187 multidrug efflux prot 99.9 5.1E-24 1.1E-28 200.2 25.9 208 46-254 230-444 (464)
10 PRK01766 multidrug efflux prot 99.9 3.2E-23 6.9E-28 194.9 25.0 207 47-254 234-442 (456)
11 COG0534 NorM Na+-driven multid 99.9 6.7E-23 1.4E-27 191.4 26.5 213 44-258 233-447 (455)
12 PRK10189 MATE family multidrug 99.9 1.5E-22 3.1E-27 190.7 28.5 211 47-258 254-466 (478)
13 PRK09575 vmrA multidrug efflux 99.9 4.1E-22 8.9E-27 186.9 27.1 206 46-254 228-436 (453)
14 TIGR01695 mviN integral membra 99.9 7E-21 1.5E-25 181.3 29.4 233 48-289 219-456 (502)
15 TIGR01695 mviN integral membra 99.9 4.9E-20 1.1E-24 175.5 34.4 271 54-332 2-282 (502)
16 PRK15099 O-antigen translocase 99.9 2.7E-20 5.9E-25 173.0 31.0 269 54-333 3-276 (416)
17 TIGR02900 spore_V_B stage V sp 99.9 6.8E-20 1.5E-24 173.9 31.1 244 55-302 2-255 (488)
18 PF03023 MVIN: MviN-like prote 99.9 1.8E-18 3.9E-23 161.7 31.7 205 48-254 194-403 (451)
19 PRK10367 DNA-damage-inducible 99.8 1.4E-18 2.9E-23 162.3 27.8 200 48-254 228-431 (441)
20 COG0728 MviN Uncharacterized m 99.8 1.5E-16 3.2E-21 147.5 34.8 238 49-294 229-471 (518)
21 TIGR02900 spore_V_B stage V sp 99.8 3.9E-18 8.4E-23 161.9 25.2 204 46-254 219-434 (488)
22 PF01554 MatE: MatE; InterPro 99.8 3.2E-20 6.9E-25 149.8 5.8 160 60-220 1-162 (162)
23 PRK15099 O-antigen translocase 99.8 1.5E-16 3.3E-21 147.9 26.7 202 46-254 209-412 (416)
24 PRK10459 colanic acid exporter 99.8 2.9E-16 6.4E-21 149.2 28.9 201 48-254 203-405 (492)
25 PF03023 MVIN: MviN-like prote 99.7 3.4E-14 7.3E-19 133.0 32.5 243 82-331 5-256 (451)
26 COG2244 RfbX Membrane protein 99.7 9E-15 2E-19 138.6 26.7 187 47-239 208-396 (480)
27 COG0728 MviN Uncharacterized m 99.7 1.2E-12 2.5E-17 121.8 33.9 274 51-330 6-289 (518)
28 PF01943 Polysacc_synt: Polysa 99.7 1.8E-12 3.9E-17 113.1 33.4 262 55-332 2-264 (273)
29 PRK10459 colanic acid exporter 99.6 7.2E-12 1.6E-16 119.2 29.7 252 51-323 4-257 (492)
30 TIGR00797 matE putative efflux 99.5 2.6E-12 5.6E-17 116.3 17.2 131 46-177 210-341 (342)
31 PF13440 Polysacc_synt_3: Poly 99.5 1.3E-09 2.8E-14 94.0 32.1 237 71-331 3-242 (251)
32 COG2244 RfbX Membrane protein 99.4 4.3E-10 9.4E-15 106.7 25.2 267 50-332 4-272 (480)
33 KOG1347 Uncharacterized membra 99.3 1.2E-11 2.6E-16 115.5 7.7 206 48-254 243-452 (473)
34 PF07260 ANKH: Progressive ank 99.0 2.5E-06 5.4E-11 73.6 27.1 248 49-304 8-268 (345)
35 PF14667 Polysacc_synt_C: Poly 98.9 1.7E-07 3.8E-12 73.9 18.0 79 174-254 2-80 (146)
36 PF04506 Rft-1: Rft protein; 98.7 2.4E-06 5.3E-11 81.3 21.4 203 51-254 252-470 (549)
37 KOG2864 Nuclear division RFT1 98.2 0.00017 3.7E-09 65.3 17.1 200 53-254 240-449 (530)
38 PF01943 Polysacc_synt: Polysa 97.6 0.00047 1E-08 59.8 9.9 71 48-119 201-272 (273)
39 PF13440 Polysacc_synt_3: Poly 96.8 0.01 2.2E-07 50.8 9.5 67 53-119 184-251 (251)
40 COG4267 Predicted membrane pro 95.6 1.6 3.6E-05 39.3 22.7 139 101-254 73-211 (467)
41 PF04506 Rft-1: Rft protein; 95.6 2.4 5.3E-05 41.0 19.3 267 56-323 5-305 (549)
42 PF02487 CLN3: CLN3 protein; 74.7 13 0.00028 34.4 7.3 29 44-72 235-263 (402)
43 COG4267 Predicted membrane pro 73.5 75 0.0016 29.2 14.2 116 126-248 320-436 (467)
44 TIGR00927 2A1904 K+-dependent 67.4 10 0.00022 38.8 5.0 34 116-149 989-1022(1096)
45 KOG2864 Nuclear division RFT1 61.3 1.5E+02 0.0032 28.1 22.6 49 50-98 6-55 (530)
46 KOG3880 Predicted small molecu 56.5 52 0.0011 29.5 7.0 33 41-73 236-268 (409)
47 PF11947 DUF3464: Protein of u 48.2 1.4E+02 0.0029 23.6 9.0 25 50-74 62-86 (153)
48 PF01102 Glycophorin_A: Glycop 45.9 34 0.00073 25.8 3.7 27 229-255 66-92 (122)
49 PF04505 Dispanin: Interferon- 42.7 1.1E+02 0.0024 21.1 6.3 33 114-146 42-74 (82)
50 PLN03100 Permease subunit of E 42.2 2.5E+02 0.0053 24.9 23.6 19 226-244 257-275 (292)
51 PRK03612 spermidine synthase; 40.4 3.5E+02 0.0076 26.2 22.0 49 201-251 149-197 (521)
52 PF03904 DUF334: Domain of unk 38.8 2.2E+02 0.0047 24.0 7.6 39 124-162 142-180 (230)
53 PF07260 ANKH: Progressive ank 36.9 1.7E+02 0.0036 26.3 7.0 61 269-329 8-69 (345)
54 KOG2234 Predicted UDP-galactos 36.6 3.3E+02 0.0071 24.7 9.6 52 236-287 51-105 (345)
55 PF05313 Pox_P21: Poxvirus P21 35.4 2.4E+02 0.0052 22.8 7.7 27 228-254 135-161 (189)
56 KOG0569 Permease of the major 35.2 4.1E+02 0.0089 25.5 17.6 34 197-232 400-433 (485)
57 PF14184 YrvL: Regulatory prot 31.6 2.4E+02 0.0052 21.6 13.5 110 134-245 6-116 (132)
58 PF05393 Hum_adeno_E3A: Human 30.7 1E+02 0.0022 21.6 3.7 29 226-254 29-57 (94)
59 TIGR00383 corA magnesium Mg(2+ 30.5 3.1E+02 0.0067 24.3 8.2 27 198-224 253-279 (318)
60 PF03303 WTF: WTF protein; In 29.3 3.5E+02 0.0077 22.9 17.5 42 51-92 88-129 (247)
61 PF08627 CRT-like: CRT-like; 28.5 2.7E+02 0.0057 21.2 7.4 28 54-81 51-78 (130)
62 PRK10739 putative antibiotic t 28.1 3.5E+02 0.0075 22.4 11.5 64 103-171 13-76 (197)
63 COG4956 Integral membrane prot 27.5 4.5E+02 0.0098 23.5 13.7 33 102-134 11-43 (356)
64 TIGR00893 2A0114 d-galactonate 25.7 4.6E+02 0.01 23.1 21.6 18 199-216 345-362 (399)
65 PRK11085 magnesium/nickel/coba 25.7 3.5E+02 0.0076 24.2 7.5 12 243-254 302-313 (316)
66 KOG0637 Sucrose transporter an 25.1 3.1E+02 0.0067 26.2 7.1 73 90-166 62-135 (498)
67 PRK11111 hypothetical protein; 25.1 4.1E+02 0.0089 22.2 9.3 62 105-171 21-82 (214)
68 PF01914 MarC: MarC family int 23.8 4.2E+02 0.0091 21.9 11.5 63 104-171 14-76 (203)
69 PF05975 EcsB: Bacterial ABC t 22.7 6.1E+02 0.013 23.3 17.0 35 124-158 89-124 (386)
70 PTZ00370 STEVOR; Provisional 21.9 1.4E+02 0.003 26.2 4.0 28 227-254 254-281 (296)
71 TIGR01478 STEVOR variant surfa 21.4 1.3E+02 0.0029 26.2 3.7 28 227-254 258-285 (295)
72 TIGR00939 2a57 Equilibrative N 20.5 2E+02 0.0044 27.0 5.2 25 49-73 262-286 (437)
73 COG4176 ProW ABC-type proline/ 20.3 5.2E+02 0.011 22.6 7.0 41 48-88 199-240 (290)
No 1
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=100.00 E-value=1.3e-39 Score=303.49 Aligned_cols=285 Identities=21% Similarity=0.311 Sum_probs=264.2
Q ss_pred HHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchh
Q 019922 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (334)
Q Consensus 47 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~ 126 (334)
.++..|+++++++|++++++++.+++.+|++++||++++++|+.++++++..++ +.+..+++.+..+++||++|+||++
T Consensus 12 ~~~~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~~~alaav~la~~i~~~~-~~~~~gl~~g~~~liaq~~Ga~~~~ 90 (455)
T COG0534 12 FKKILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLGAEALAAVGLANPIFFLI-IAIFIGLGTGTTVLVAQAIGAGDRK 90 (455)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHHHH-HHHHHHHHHhHHHHHHHHHcCCchH
Confidence 467899999999999999999999999999999999999999999999999985 7899999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHH-HHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 127 MLGVYMQRSWIVLFICCVLL-LPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
++++..++.+.+++.++++. .+.+++.++++.+++.++++.+.+.+|+++..++.|+..+..++.+++|+.||+|.+++
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~m~ 170 (455)
T COG0534 91 KAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKTPMY 170 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchhHH
Confidence 99999999999999999555 55677999999999998889999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHh-hc-cCchhHHHHHHHHHHHHHHHHHHHHHhcC--CCCccCCCCHHhHhhHHHHHHHHHHH
Q 019922 206 VSLASLLVHLLVTWLFVYK-MQ-LGLIGTAITLSFSWWVLIFGMFGYVACGG--CPRTWTGFSMEAFSDLWEFVKLSVAS 281 (334)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~-~~-~g~~G~~ia~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~p~ 281 (334)
++++++++|+++|++|+++ ++ ||+.|+++||.+++.+..++..+++++++ .+....+..+.+++.+|+++++|+|.
T Consensus 171 ~~~~~~~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lG~p~ 250 (455)
T COG0534 171 ILLLGNLLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLLLIYLLRKKRLLSLFKKKLLKPDRKLLKEILRLGLPI 250 (455)
T ss_pred HHHHHHHHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhccCCCHHHHHHHHHhcccH
Confidence 9999999999999999998 46 99999999999999999999999998874 23333344456778999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhccC
Q 019922 282 GVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGTG 334 (334)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~s 334 (334)
+++...+...+.+.+.+++++|+ .++|+|++..++.++.++++.|+++|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~G~--~~lAa~~i~~~i~~~~~~~~~gi~~a~~ 301 (455)
T COG0534 251 FLESLSESLGFLLLTLFVARLGT--VALAAYGIALRIASFIFMPPFGIAQAVT 301 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCh--HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999995 3677999999999999999999999863
No 2
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=100.00 E-value=2.2e-36 Score=281.56 Aligned_cols=284 Identities=14% Similarity=0.153 Sum_probs=253.2
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchh
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHL-GDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~ 126 (334)
+++.|+++++++|.+++++++.+++.+|+.++|++ |++++|+++++.++.+.. ..+..+++.+..+++||++|+||+|
T Consensus 5 ~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g~~alAa~~l~~~i~~~~-~~~~~~~~~g~~~lvsq~~Ga~~~~ 83 (441)
T PRK10367 5 TSSDKALWRLALPMIFSNITVPLLGLVDTAVIGHLDSPVYLGGVAVGATATSFL-FMLLLFLRMSTTGLTAQAFGAKNPQ 83 (441)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 35688999999999999999999999999999998 677999999999998874 6788899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
++++..++++.++++++++..++ ..+.++++.+++.|+|+.+.+.+|+++..++.|+..+..++.+++|+.||+|.+++
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 163 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVI 163 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHH
Confidence 99999999999999999877655 55888999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc-CCCC-ccCCCCHHhHhhHHHHHHHHHHHHH
Q 019922 206 VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG-GCPR-TWTGFSMEAFSDLWEFVKLSVASGV 283 (334)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~l~~~~p~~~ 283 (334)
.++++.++|+++++++++++++|+.|+++|+.+++.+..++..++++++ +.+. +.+.++...++.+|++++++.|.++
T Consensus 164 ~~ii~~~vni~l~~~lI~~~~lGv~Gaa~At~is~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~ 243 (441)
T PRK10367 164 LLVVGNILNIVLDLWLVMGLHMNVQGAALATVIAEYATLLIGLLMVRKVLKLRGISLEMLKTAWRGNFRRLLALNRDIML 243 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHhhhhhHHHHHHHHHhCchHHH
Confidence 9999999999999999998899999999999999999888877777654 2221 1111111112468999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhccC
Q 019922 284 MLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGTG 334 (334)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~s 334 (334)
+...+...+.+.+.+++++|+. ++|+|++..++.++.++++.|+++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~G~~--alAa~~I~~~i~~~~~~~~~gl~~a~~ 292 (441)
T PRK10367 244 RSLLLQLCFGAITVLGARLGSD--IIAVNAVLMTLLTFTAYALDGFAYAVE 292 (441)
T ss_pred HHHHHHHHHHHHHHHHHhcCHH--HHHHHHHHHHHHHHHHHHHHhHHHHHH
Confidence 9999999999999999999953 678999999999999999999999863
No 3
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=100.00 E-value=5.9e-36 Score=280.93 Aligned_cols=285 Identities=19% Similarity=0.208 Sum_probs=255.7
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
+++++.|+++++++|.+++++.+.+.+.+|+++++++|++++|+++++.++.+++ ..+..|++.+..+++||++|++|+
T Consensus 4 ~~~~~~k~il~~a~P~~~~~~~~~~~~~~d~~~v~~lg~~alAa~~i~~~i~~~~-~~~~~gl~~~~~~i~aq~~Ga~~~ 82 (464)
T PRK00187 4 PPTTELKAILRLAGPLIASQLAHMLMVFTDTLMMGRLGPEALAGGGLGAASYSFV-SIFCVGVIAAVGTLVAIRHGAGDI 82 (464)
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCCh
Confidence 3467899999999999999999999999999999999999999999999998875 678899999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 126 YMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
|++++.+++++.+..+++++..+++++.++++.+++.|+|+.+.+.+|+++..++.|+..+...+++++|+.||++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 162 (464)
T PRK00187 83 EGATRLAQAGLWLAWLLALVAALLLWNLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVMV 162 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHH
Confidence 99999999999999999987766666789999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhh----ccCchhHHHHHHHHHHHHHHHHHHHHHhcC-C-CCc-cCCCCHHhHhhHHHHHHHH
Q 019922 206 VSLASLLVHLLVTWLFVYKM----QLGLIGTAITLSFSWWVLIFGMFGYVACGG-C-PRT-WTGFSMEAFSDLWEFVKLS 278 (334)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~----~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~-~-~~~-~~~~~~~~~~~~~~~l~~~ 278 (334)
.++++.++|+++||+|+++. ++|+.|+++|+.+++....+.+.+++++++ . +.+ +.++.+.+++.+|++++++
T Consensus 163 ~~~~~~~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~lg 242 (464)
T PRK00187 163 ISLAGAVANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMALALALYIRRHPAYAAYPLRKGLSRPSRAALRELWRLG 242 (464)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhccccCCCHHHHHHHHHhh
Confidence 99999999999999999863 489999999999999888877766666542 1 111 1122234567899999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhcc
Q 019922 279 VASGVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGT 333 (334)
Q Consensus 279 ~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~ 333 (334)
+|.+++...+...+.+++.+++++|+. ++|++++..++..+.++++.|+++|+
T Consensus 243 ~P~~~~~~~~~~~~~i~~~~i~~~G~~--alAa~~i~~~i~~l~~~~~~gi~~a~ 295 (464)
T PRK00187 243 LPIGGTYAVEVGLFTFAALCMGALGST--QLAAHQIALQIVSVAFMVPVGLSYAV 295 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHcCHH--HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999964 67799999999999999999999875
No 4
>PRK10189 MATE family multidrug exporter; Provisional
Probab=100.00 E-value=6.9e-35 Score=274.02 Aligned_cols=283 Identities=13% Similarity=0.196 Sum_probs=251.6
Q ss_pred HHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhH
Q 019922 49 IESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYML 128 (334)
Q Consensus 49 ~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~ 128 (334)
+..|+++++++|.++++++..+.+.+|+.+++++|++++|+++++.++..+. +.+..|++.+..++++|++|++|+|++
T Consensus 26 ~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~lG~~alAA~~i~~~i~~~~-~~~~~gl~~g~~~lvsq~~Ga~~~~~~ 104 (478)
T PRK10189 26 LFWREITPLAVPIFIENLCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVI-MAFFAAIDLGTTVVVAFSLGKRDRRRA 104 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCCHHHH
Confidence 3599999999999999999999999999999999999999999999998874 788999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcC--CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 129 GVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLG--QPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 129 ~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
++..++++.++..++++..++ +++.++++.+++ .|+|+.+.+..|+++..++.|+..+...+.+++|+.||++.+++
T Consensus 105 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 184 (478)
T PRK10189 105 RAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRGAGNTKIPLL 184 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCchHHhHH
Confidence 999999999999999776655 558899999884 68999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhh----ccCchhHHHHHHHHHHHHHHHHHHHHHhc-C--CCCccCC-CCHHhHhhHHHHHHH
Q 019922 206 VSLASLLVHLLVTWLFVYKM----QLGLIGTAITLSFSWWVLIFGMFGYVACG-G--CPRTWTG-FSMEAFSDLWEFVKL 277 (334)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~----~~g~~G~~ia~~i~~~~~~~~~~~~~~~~-~--~~~~~~~-~~~~~~~~~~~~l~~ 277 (334)
+++++.++|++++++++++. ++|+.|+|+|+.+++.+..++..+++.++ + .+.++++ +.+.+++.+|+++++
T Consensus 185 i~~~~~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~i 264 (478)
T PRK10189 185 INGGMNILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAIIWVLMIGFNPALRISLKSYFKPLNFAIIWEVMGI 264 (478)
T ss_pred HHHHHHHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeeccccccCCHHHHHHHHHH
Confidence 99999999999999999864 78999999999999999888776666543 2 2222222 122356789999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhccC
Q 019922 278 SVASGVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGTG 334 (334)
Q Consensus 278 ~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~s 334 (334)
|+|.+++.......+.+.+.+++++|+ .++|+|+++.++.++.++++.|+++|++
T Consensus 265 G~P~~~~~~~~~~~~~~~~~~~~~~G~--~~~Aa~~I~~~i~~~~~~~~~gi~~A~~ 319 (478)
T PRK10189 265 GIPASIESVLFNGGKLLTQMFVAGMGT--SVIAGNFIAFSIAALINLPGNALGSAST 319 (478)
T ss_pred hccHHHHHHHHHHHHHHHHHHHHHcCH--HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999988888888888889999995 4678999999999999999999998863
No 5
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=100.00 E-value=4.7e-34 Score=267.58 Aligned_cols=285 Identities=17% Similarity=0.165 Sum_probs=255.1
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchh
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHL-GDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~ 126 (334)
++..|+++++++|.+++++...+++++|+.+++++ |++++++++++.++..+. ..+..+++.+..++++|++|+||+|
T Consensus 8 ~~~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g~~~laa~~~~~~~~~~~-~~~~~~~~~g~~~lvsq~~Ga~~~~ 86 (453)
T PRK09575 8 QSIYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVGAEGLAGINMAWPVIGII-LGIGLMVGMGTGSLLSIKRGEGDLE 86 (453)
T ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHHHHHHH-HHHHHHHhccHHHHHHHHhcCCCHH
Confidence 35789999999999999999999999999999995 999999999999998874 6788899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
++++.+++.+.++.+++++..++ +.+.++++.+++.|+++.+.+.+|+++..++.++..+...+.+++|+.||++.+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 166 (453)
T PRK09575 87 KAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPNLATG 166 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99999999999999999777655 55899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCCccC-CCCHHhHhhHHHHHHHHHHHHHH
Q 019922 206 VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWT-GFSMEAFSDLWEFVKLSVASGVM 284 (334)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~p~~~~ 284 (334)
.++++.++|+++++++++++++|+.|+++|+.+++++..++..+++++++.+.+++ +..+.+++.+|+++++|+|.+++
T Consensus 167 ~~~~~~~~ni~l~~~li~~~~~Gi~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~~ 246 (453)
T PRK09575 167 LMVIGALINIVLDYLFIGWLDWGLTGAAIATALAQLVVTVLGLGYFFSSRANIRLTLKELRFNWSLAPKIVLLGSSSFFM 246 (453)
T ss_pred HHHHHHHHHHHhhHHHHHhCCchhHHHHHHHHHHHHHHHHHHHHHHHCCCceeEEeeccCCcCHHHHHHHHHhChhHHHH
Confidence 99999999999999999988899999999999999999988877776553222222 11234567799999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhccC
Q 019922 285 LCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGTG 334 (334)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~s 334 (334)
...+...+.+.+.+++++|+. .++|+|++..++..+.+++..|++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~g~~-~~lAa~~i~~~i~~~~~~~~~gi~~a~~ 295 (453)
T PRK09575 247 YLYGSFVVALHNRLFMEYGSA-LTVGAYAIVGYLMVLYYLVAEGIAEGMQ 295 (453)
T ss_pred HHHHHHHHHHHHHHHHHhCch-HHHHHHHHHHHHHHHHHHHHHHHHHhhH
Confidence 999999999999999999853 3578999999999999999999998763
No 6
>PRK01766 multidrug efflux protein; Reviewed
Probab=100.00 E-value=9.3e-33 Score=259.53 Aligned_cols=285 Identities=20% Similarity=0.356 Sum_probs=253.5
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
.+++.+|+++++++|.+++++...+.+.+|+.+++++|++++++++++.++...+ ..+..|++.+..+.+||++|++|+
T Consensus 6 ~~~~~~~~il~~~~P~~~~~~~~~~~~~~d~~~i~~~g~~~laa~~~~~~~~~~~-~~~~~g~~~a~~~~vs~~~g~~~~ 84 (456)
T PRK01766 6 KYKSEARQLLALALPILLAQVAQTAMGFVDTVMAGGVSATDLAAVAIGTSIWLPV-ILFGHGLLLALTPIVAQLNGAGRR 84 (456)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCCh
Confidence 4567899999999999999999999999999999999999999999999887663 677889999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHH
Q 019922 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (334)
|+.++.+++++.+.+.+++++.++ +.+.++++.+++.|++..+.+..|+++.+++.++..+..++.+++++.|+++.++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 164 (456)
T PRK01766 85 ERIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPTM 164 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 999999999999999999877665 4477889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHh----hccCchhHHHHHHHHHHHHHHHHHHHHHhcC-CC--CccCCCCHHhHhhHHHHHHH
Q 019922 205 WVSLASLLVHLLVTWLFVYK----MQLGLIGTAITLSFSWWVLIFGMFGYVACGG-CP--RTWTGFSMEAFSDLWEFVKL 277 (334)
Q Consensus 205 ~~~~~~~~~~i~l~~~li~~----~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~l~~ 277 (334)
+.++++.++|++++++++++ ..+|+.|+++++.+++++..++..+++++++ .+ +.+.++.+++++.+|+++++
T Consensus 165 ~~~~i~~ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~l 244 (456)
T PRK01766 165 VIGFLGLLINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRARRFRDFRLFKGLYKPDWAVIKRLLKL 244 (456)
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhChhhhHHHhhccccCCCHHHHHHHHHc
Confidence 99999999999999999964 2589999999999999999998888876652 21 11222223456789999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhcc
Q 019922 278 SVASGVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGT 333 (334)
Q Consensus 278 ~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~ 333 (334)
++|..++...+...+.+.+.+++++|+. ++|++++..++.++.++++.|++.|+
T Consensus 245 ~~P~~~~~~~~~~~~~~~~~~~~~~G~~--~lAa~~i~~~i~~~~~~~~~gl~~a~ 298 (456)
T PRK01766 245 GLPIGLAIFFEVSLFAVVTLLVSPLGTV--TVAAHQIALNFSSLLFMLPLSLAMAL 298 (456)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHcChH--HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999954 57799999999999999999998875
No 7
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.97 E-value=2.4e-28 Score=221.28 Aligned_cols=271 Identities=25% Similarity=0.487 Sum_probs=240.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHH
Q 019922 60 PTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVL 139 (334)
Q Consensus 60 p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 139 (334)
|.++++++..+...+|+.+++++|++++++++++.++..+. ..+..+++++..|.++++.|++|+|+.++..++...+.
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~a~~i~~~~-~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 79 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLGPVDLAAVSLGSSVFMFL-FSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLLA 79 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHhHHHHHHH-HHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHHH
Confidence 78899999999999999999999999999999999987764 67889999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHHHHHHHHH
Q 019922 140 FICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVT 218 (334)
Q Consensus 140 ~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~ 218 (334)
..++++..++ +.+.+++..+++.+++..+.+..+++++.++.++..+..+..+.+++.||++...+.++++.+++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~~~~i~~~ 159 (342)
T TIGR00797 80 LLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGNVINIILN 159 (342)
T ss_pred HHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHHh
Confidence 9999777655 558889988888788888899999999999999999999999999999999999999999999999999
Q ss_pred HHHHH-hhc-cCchhHHHHHHHHHHHHHHHHHHHHHhc-CCCCccCCCCHHhHhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 019922 219 WLFVY-KMQ-LGLIGTAITLSFSWWVLIFGMFGYVACG-GCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYRVL 295 (334)
Q Consensus 219 ~~li~-~~~-~g~~G~~ia~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~ 295 (334)
+++++ .++ +|+.|+++++.+++++..++..++.+|+ +.+.+|+...+.+++.+|+++++++|..+.....++.+.++
T Consensus 160 ~~li~~~~g~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~ 239 (342)
T TIGR00797 160 YILIFGKFGFLGIVGAALATVISYWLMFLLLLYYIKKAKKIGLKWEGLLKPDWEVLKRLLKLGLPIAFRVILESLSFALL 239 (342)
T ss_pred HHHHhcCccccccHHHHHHHHHHHHHHHHHHHHHHHhCCCcccccccccCCCHHHHHHHHHhCchHHHHHHHHHHHHHHH
Confidence 99987 557 8899999999999999998888777764 33333333334456789999999999999999999999999
Q ss_pred HHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhcc
Q 019922 296 ILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGT 333 (334)
Q Consensus 296 ~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~ 333 (334)
+.+++.+|.+ ++++|+++.++.++..+++.+++++.
T Consensus 240 ~~i~~~~g~~--~v~~~~~a~~~~~~~~~~~~~~~~a~ 275 (342)
T TIGR00797 240 ALLVARLGSI--ALAAHQIALNVESLLFMPAFGFGIAV 275 (342)
T ss_pred HHHHHHcCcH--HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999854 56799999999999999999988764
No 8
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.97 E-value=9.7e-28 Score=222.57 Aligned_cols=288 Identities=42% Similarity=0.754 Sum_probs=274.3
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
....+.|++++++.|.++..+.+.+...+++.++||+|+.++++.+++....+...+.+..|+..+..++++|++|++++
T Consensus 22 ~~~~e~k~l~~ia~P~i~~~~~~~~~~~is~~f~GhlG~leLaa~sla~s~~n~~~~s~~~gl~~aletlcgQa~ga~~~ 101 (473)
T KOG1347|consen 22 QLVTESKELARLALPAILTFLAQPLLSLVSTAFAGHLGNLELASVSLANSFANITGVSILLGLQLALDTLCGQAFGAKKF 101 (473)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhhccccchHHHHHHHHHHhhcccchHHhhccchhhhcchHhhhccccc
Confidence 33789999999999999999999999999999999999999999999999999878899999999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 126 YMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
+....+.+++.......++|....+.+.++++..++.|+++.+.+..|.++..++.+.+.....+..+++++++..+..+
T Consensus 102 ~~lg~~lqrs~~~l~~~~~~~~~l~~~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~~ 181 (473)
T KOG1347|consen 102 TALGVYLQRSGIVLLVQGLPISLLILNSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLLV 181 (473)
T ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHHHH
Q 019922 206 VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVML 285 (334)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~ 285 (334)
+..+..++|++++|++++..++|..|++++..+++++...++..|......+..|..+..+ ++.+++++++++|.+++.
T Consensus 182 ~~~~~~~lhi~~~~llv~~~~~g~~Gaala~~~s~w~~~~~l~~yi~~~~~~~~w~~~s~~-~~~~~~~~~lai~s~~mi 260 (473)
T KOG1347|consen 182 IGLVALVLHILLTWLLVSKLGLGIKGAALALVASYWLNVRILLLYAVLSGCLAAWSGFSGE-FDSWGPFFALAIPSAVMI 260 (473)
T ss_pred HHHHHHHHHHHHHHHhhhcccCCCccchHHHHHHHHHHHHHHHHHheecCchhhhhhhhHh-hhhHHHHHHHhhcchhee
Confidence 9999999999999999999999999999999999999999998888776666777777777 899999999999999999
Q ss_pred HHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhccC
Q 019922 286 CLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAGTG 334 (334)
Q Consensus 286 ~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a~s 334 (334)
.+|+|.+.+.....+.+++.+.++++.+|..++.+..++++.|++.|+|
T Consensus 261 clE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~~~~~~~~~~a~s 309 (473)
T KOG1347|consen 261 CLEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWHLMIPGAFSAAVS 309 (473)
T ss_pred HHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHhhhhhhhHH
Confidence 9999999999999999999888899999999999999999999998864
No 9
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=99.93 E-value=5.1e-24 Score=200.24 Aligned_cols=208 Identities=16% Similarity=0.175 Sum_probs=190.0
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
..++..|+++|+++|.+++++.+.....+|+.+++++|++++|+++++.++..+ .+.+..|++.+..++++|++|+||+
T Consensus 230 ~~~~~~k~il~lg~P~~~~~~~~~~~~~i~~~~i~~~G~~alAa~~i~~~i~~l-~~~~~~gi~~a~~~lvgq~~Ga~~~ 308 (464)
T PRK00187 230 PSRAALRELWRLGLPIGGTYAVEVGLFTFAALCMGALGSTQLAAHQIALQIVSV-AFMVPVGLSYAVTMRVGQHYGAGRL 308 (464)
T ss_pred CCHHHHHHHHHhhhhHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHcCCCH
Confidence 346679999999999999999999999999999999999999999999999887 4789999999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCC--CH---HHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcch
Q 019922 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQ--PD---DVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLK 199 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~--~~---~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~ 199 (334)
|++++..+.++.++.+.+++..++ +.+.+++.+.+.+ ++ |+.+.+..|+++.+++.++..++.++.+.+|+.||
T Consensus 309 ~~~~~~~~~~l~~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~G~ 388 (464)
T PRK00187 309 LEARRAGRVGIGFGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGLKD 388 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhccCc
Confidence 999999999999999999766655 6689999998853 33 68888999999999999999999999999999999
Q ss_pred hhHHHHHHHHHH-HHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 200 TMVIAWVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 200 ~~~~~~~~~~~~-~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
++.++++++++. ++++++++++.+.+++|+.|+|+++.+++++..++.....+++
T Consensus 389 ~~~~~~~~~~~~~~~~ipl~~ll~~~~~~g~~Gvw~~~~i~~~~~~~~~~~~~~~~ 444 (464)
T PRK00187 389 ARTTFLIGLACYWLVGAPLAWLLAFTLGWGAVGVWWGLALGLACAAVALTLAFEWK 444 (464)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHhccCCCceeeHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999998 8999999999987789999999999999999887776666443
No 10
>PRK01766 multidrug efflux protein; Reviewed
Probab=99.92 E-value=3.2e-23 Score=194.92 Aligned_cols=207 Identities=20% Similarity=0.199 Sum_probs=192.5
Q ss_pred HHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchh
Q 019922 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (334)
Q Consensus 47 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~ 126 (334)
.++..|++++.++|..++.+.+.+...++..+++++|++++++++++.++.++. +.+..|++.+..+.++|++|+||++
T Consensus 234 ~~~~~k~il~l~~P~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~~~-~~~~~gl~~a~~~~v~~~~Ga~~~~ 312 (456)
T PRK01766 234 DWAVIKRLLKLGLPIGLAIFFEVSLFAVVTLLVSPLGTVTVAAHQIALNFSSLL-FMLPLSLAMALTIRVGFELGAGRTL 312 (456)
T ss_pred CHHHHHHHHHccchHHHHHHHHHHHHHHHHHHHHHcChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCCHH
Confidence 356799999999999999999999999999999999999999999999998875 7789999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
++++..+.++.++..++++..++ +.+.+++..+++.|+++.+.+..++++..++.++..++.+..+++||.||++.+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~~~ 392 (456)
T PRK01766 313 DARQYAYIGLAVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVIFF 392 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHHHH
Confidence 99999999999999999776655 55999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHH-HHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 206 VSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 206 ~~~~~~-~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
.++++. ++++++.+++.+..++|+.|+|+++.+++.+..++..+++++.
T Consensus 393 ~~~~~~~~~~i~~~~~l~~~~~~G~~G~~~~~~~~~~~~~~~~~~~~~~~ 442 (456)
T PRK01766 393 ITFIAYWVLGLPLGYILALTDPMGPFGFWIGLIIGLTAAAILLLLRLRKL 442 (456)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCCceehHHHHHHHHHHHHHHHHHHHHHH
Confidence 999988 7899999999887789999999999999999998887777654
No 11
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=99.92 E-value=6.7e-23 Score=191.41 Aligned_cols=213 Identities=21% Similarity=0.257 Sum_probs=197.4
Q ss_pred hHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccC
Q 019922 44 TRRFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGK 123 (334)
Q Consensus 44 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~ 123 (334)
.+++++..|++++.++|..++++.......+-+.+++++|++.+|+++++.++.++. +.+..|++++.+++++|++|+|
T Consensus 233 ~~~~~~~~~~i~~lG~p~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~~~-~~~~~gi~~a~~~lvG~~~Ga~ 311 (455)
T COG0534 233 LKPDRKLLKEILRLGLPIFLESLSESLGFLLLTLFVARLGTVALAAYGIALRIASFI-FMPPFGIAQAVTILVGQNLGAG 311 (455)
T ss_pred cCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCC
Confidence 345678999999999999999999999999999999999999999999999999985 8899999999999999999999
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhH
Q 019922 124 KYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (334)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (334)
|+|++++..+.+..++..+++...++ +.+++++..+|.+|+++.+.+..++++..+..++.+.+.+..+.+||.||++.
T Consensus 312 ~~~~a~~~~~~~~~~~~~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~~~ 391 (455)
T COG0534 312 NYKRARRAARLALKLSLLIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDAKI 391 (455)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcHH
Confidence 99999999999999999999766555 66999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHH-HHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCC
Q 019922 203 IAWVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPR 258 (334)
Q Consensus 203 ~~~~~~~~~-~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~ 258 (334)
+++.++++. .+.+++.+++.+.. +|..|+|++..+++.+..++..++.++++++.
T Consensus 392 ~~~~~~~~~~~~~lp~~~~l~~~~-~g~~Gvw~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (455)
T COG0534 392 PFIISLLSYWGFRLPLAYLLGFFF-LGLAGVWIGFPLSLILRAILLLLRLRRGRWRR 447 (455)
T ss_pred HHHHHHHHHHHHHHhHHHHHhhhc-ccchHHHHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 999999998 67789999988854 99999999999999999999988888764443
No 12
>PRK10189 MATE family multidrug exporter; Provisional
Probab=99.92 E-value=1.5e-22 Score=190.67 Aligned_cols=211 Identities=14% Similarity=0.118 Sum_probs=194.0
Q ss_pred HHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchh
Q 019922 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (334)
Q Consensus 47 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~ 126 (334)
+++.+|++++.++|..++.+...+...+.+.+++++|++++|+++++.++.++. +.+..|++++.+++++|++|+||.+
T Consensus 254 ~~~~~~~il~iG~P~~~~~~~~~~~~~~~~~~~~~~G~~~~Aa~~I~~~i~~~~-~~~~~gi~~A~~~lvg~~~Ga~~~~ 332 (478)
T PRK10189 254 NFAIIWEVMGIGIPASIESVLFNGGKLLTQMFVAGMGTSVIAGNFIAFSIAALI-NLPGNALGSASTIITGTRLGKGQIA 332 (478)
T ss_pred CHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 457899999999999999999999999999999999999999999999999884 7789999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
++++..+.+..++.+.++.+.++ +.+++++..+|.+|+|+.+.+..++++.++..++.+++.+..+.+||.||++.+++
T Consensus 333 ~a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~~ 412 (478)
T PRK10189 333 QAERQLRHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAMW 412 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHHH
Confidence 99999999999999999766655 55999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHH-HHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCC
Q 019922 206 VSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPR 258 (334)
Q Consensus 206 ~~~~~~-~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~ 258 (334)
+++.+. ++.+++.+++....++|+.|+|++..+++.+..++..+.+++.+|++
T Consensus 413 i~~~~~~~v~ip~~~ll~~~~~~g~~Gvw~~~~~~~~~~~~~~~~r~~~~~W~~ 466 (478)
T PRK10189 413 VSMLGMWGCRVVAGYILGIMLGFGVVGVWMGMFLDWAVRGVLFYWRMVSGRWLW 466 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 999988 78889999988777899999999999999999988777776665555
No 13
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=99.91 E-value=4.1e-22 Score=186.92 Aligned_cols=206 Identities=14% Similarity=0.201 Sum_probs=188.0
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccCh-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCc
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGD-LELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKK 124 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~-~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~ 124 (334)
.+++..|++++++.|..++.....+...+.+.+++++|+ +++|+++++.++..+. +.+..|++.+..++++|++|+||
T Consensus 228 ~~~~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~g~~~~lAa~~i~~~i~~~~-~~~~~gi~~a~~~lvg~~~Ga~~ 306 (453)
T PRK09575 228 FNWSLAPKIVLLGSSSFFMYLYGSFVVALHNRLFMEYGSALTVGAYAIVGYLMVLY-YLVAEGIAEGMQPPVSYYFGARQ 306 (453)
T ss_pred cCHHHHHHHHHhChhHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHHHHHHHHH-HHHHHHHHHhhHHHHHHHhcCCC
Confidence 446788999999999999999999999999999999985 6899999999998874 78999999999999999999999
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCC-CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhH
Q 019922 125 YYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQ-PDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (334)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (334)
+|++++..++++.+++..+++..++ +.+.+++..+++. |+|+.+.+..|+++..++.++..+..+..+++||.||++.
T Consensus 307 ~~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~~~ 386 (453)
T PRK09575 307 YDNIKKLLKLAMKVTVLAGIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQGGK 386 (453)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHH
Confidence 9999999999999999999877665 5599999999985 7899999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 203 IAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 203 ~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
+++.++...++++++.+++.. .+|+.|+|+++.+++.+..++..++++++
T Consensus 387 ~~~~~~~~~~v~ip~~~ll~~--~~G~~Gvw~a~~~~~~~~~~~~~~~~~~~ 436 (453)
T PRK09575 387 ALFISIGNMLIQLPFLFILPK--WLGVDGVWLAMPLSNIALSLVVAPMLWRD 436 (453)
T ss_pred HHHHHHHhHHHHHHHHHHHHH--HHCcchHhhHHHHHHHHHHHHHHHHHHHH
Confidence 999999888889999988875 48999999999999999888887777654
No 14
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.90 E-value=7e-21 Score=181.28 Aligned_cols=233 Identities=16% Similarity=0.111 Sum_probs=198.9
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhh
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYM 127 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~ 127 (334)
++..|++++.+.|..++++...+...+|+.+.+.+|++++++++.+.++.++....+..+++++..|.++++.|++|+++
T Consensus 219 ~~~~k~~l~~~~p~~~~~~~~~~~~~id~~~~~~~~~~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~~ 298 (502)
T TIGR01695 219 DPGLKRFLKLFLPTTLGSSASQITLLINTALASFLEIGSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWNE 298 (502)
T ss_pred ChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHH
Confidence 45789999999999999999999999999886668999999999999998864344678999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCC----CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhH
Q 019922 128 LGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQ----PDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (334)
Q Consensus 128 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (334)
.++.+++...+...+++|..++ +.+++++..++.+ +++..+.+..++++++++.++..+..++.+.+++.||++.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~~ 378 (502)
T TIGR01695 299 LRDLLNQGIRLSLLLTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTRT 378 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCcc
Confidence 9999999999999999888766 5589999888754 5567778899999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHH
Q 019922 203 IAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASG 282 (334)
Q Consensus 203 ~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~ 282 (334)
+++.++...++|++++++++. .+|+.|+|+|+.+++.+..++..++++|+.... +..+..+++.|..++..
T Consensus 379 ~~~~~~~~~~i~i~l~~~l~~--~~G~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~as~ 449 (502)
T TIGR01695 379 PFINSVISVVLNALLSLLLIF--PLGLVGIALATSAASMVSSVLLYLMLNRRLKGI-------LPFGVLKVLAKLVIASA 449 (502)
T ss_pred CHHHHHHHHHHHHHHHHHHHH--HHhhhHHHHHHHHHHHHHHHHHHHHHHHhcCcC-------CchHHHHHHHHHHHHHH
Confidence 999999999999999999987 589999999999999999888877777651111 11244666677666666
Q ss_pred HHHHHHH
Q 019922 283 VMLCLEN 289 (334)
Q Consensus 283 ~~~~~~~ 289 (334)
++.....
T Consensus 450 ~m~~~~~ 456 (502)
T TIGR01695 450 IIGGVLY 456 (502)
T ss_pred HHHHHHH
Confidence 6655443
No 15
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.89 E-value=4.9e-20 Score=175.47 Aligned_cols=271 Identities=15% Similarity=0.098 Sum_probs=210.8
Q ss_pred HHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHH-HHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhccCchhhHHH
Q 019922 54 LWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLEL-AAISIANTVVVAFNFGLL-LGMASALETLCGQAFGGKKYYMLGV 130 (334)
Q Consensus 54 ~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~-a~~~i~~~~~~~~~~~~~-~~i~~~~~~~~s~~~g~~~~~~~~~ 130 (334)
++|-+.-..++++++.+++++|.+++++ +|++++ ++++++.++.+.+..... .|++.+..+...++.+++ |+.++
T Consensus 2 ~~k~~~i~~~~~~~~~~~~~~~~~~~a~~lG~~~~~~~~~~~~~i~~~~~~~~~~~g~~~a~i~~~~~~~~~~--~~~~~ 79 (502)
T TIGR01695 2 LLKSTLIVSLGTLFSRITGFVRDAIIASAFGAGLTADAFNVAFVIPNFFRRLFAEGAFNSAFVPVFTKAKKKE--KEARR 79 (502)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChHhhHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhh--hHHHH
Confidence 5678888999999999999999999999 899999 899999999875423323 467777777776654332 57777
Q ss_pred HHHHHHHHHHHHH-HHHHH-HHHhhHHHHHHc--CCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHH
Q 019922 131 YMQRSWIVLFICC-VLLLP-LYVFASPVLKLL--GQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWV 206 (334)
Q Consensus 131 ~~~~~~~~~~~~~-i~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 206 (334)
.+.+.......++ ++..+ .+++++++..++ +.+++..+.+..|+++..++.++..+....++++|+.||++.+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 159 (502)
T TIGR01695 80 AFANTVTTLLILSLLLVVLIGIFFAPFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPSFS 159 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHHHH
Confidence 7777666655554 44444 455778888877 4567777889999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhccCchhHH--HHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHHH
Q 019922 207 SLASLLVHLLVTWLFVYKMQLGLIGTA--ITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVM 284 (334)
Q Consensus 207 ~~~~~~~~i~l~~~li~~~~~g~~G~~--ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~ 284 (334)
+++..+++++..+++.. ++|..|++ +++.+++.+..++..++.+|++.+.+. ++ +.+++.+|++++.+.|..+.
T Consensus 160 ~i~~~i~~i~~~~~~~~--~~g~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~k~~l~~~~p~~~~ 235 (502)
T TIGR01695 160 PILFNIGVILSLLFFDW--NYGQYSLALAIGVLIGGVAQLLIQLPFLRKAGFLLKP-RF-NFRDPGLKRFLKLFLPTTLG 235 (502)
T ss_pred HHHHHHHHHHHHHHHHc--ccchHHHHHHHHHHHHHHHHHHHHHHHHHHCCCcccC-cC-CCCChhHHHHHHHHHHHHHH
Confidence 99998887775544444 79999998 999999999888887777665322111 11 12446789999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHH-HHHhhhhc
Q 019922 285 LCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELM-IPLSFFAG 332 (334)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~-~~~~~~~a 332 (334)
....++...++..+.+.+|.+ ++++|+++.++..+... +..+++++
T Consensus 236 ~~~~~~~~~id~~~~~~~~~~--~v~~~~~a~~l~~~~~~~~~~~i~~~ 282 (502)
T TIGR01695 236 SSASQITLLINTALASFLEIG--SVSALYYANRIYQLPLGIFGISLSTV 282 (502)
T ss_pred HHHHHHHHHHHHHHHhcCCcc--hHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999887777754 46699999999887654 44555543
No 16
>PRK15099 O-antigen translocase; Provisional
Probab=99.89 E-value=2.7e-20 Score=173.03 Aligned_cols=269 Identities=12% Similarity=0.025 Sum_probs=215.6
Q ss_pred HHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHH
Q 019922 54 LWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYM 132 (334)
Q Consensus 54 ~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~ 132 (334)
++|-+.....+++...+.+++-..+++| +|++++|.++..+++..++......|++++....++|+ ++|+++.++.+
T Consensus 3 ~~k~~~~~~~~~~~~~~~~~l~~~i~ar~Lg~~~~G~~~~~~~~i~~~~~~~~~G~~~a~~~~ia~~--~~~~~~~~~~~ 80 (416)
T PRK15099 3 LAKASLWTAASTLVKIGAGLLVVKLLAVSFGPAGVGQAGNFRQLITVLGVLAGAGIFNGVTKYVAQY--HDQPQQLRAVV 80 (416)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCcHHHHHHHHHHHHHHHHHHHHcCCccceeeeeHHhc--CCCHHHHHHHH
Confidence 5677778888999999999999999999 79999999999998888655545778888888888988 67888999999
Q ss_pred HHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHH
Q 019922 133 QRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASL 211 (334)
Q Consensus 133 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 211 (334)
..++.+.+..+++..+. +.+.+++...++.+++.. .++.+..+..++..+.....+.+|+.||++.++...+++.
T Consensus 81 ~~~~~l~~~~~~i~~~~~~~~~~~i~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~lr~~~~~~~~~~~~~~~~ 156 (416)
T PRK15099 81 GTSSAMVLGFSTLLALVFLLAAAPISQGLFGHTDYQ----GVVRAVALIQMGIAWANLLLAILKGFRDAAGNALSLIVGS 156 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChhHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999998766554 668889888777666532 3566666666677888899999999999999999999999
Q ss_pred HHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc-CCCCccCCCCHHhHhhHHHHHHHHHHHHHHHHHHHH
Q 019922 212 LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG-GCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENW 290 (334)
Q Consensus 212 ~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~ 290 (334)
++|+.+ +++... .+|+.|+++|+.+++.+..+...++++|+ +.+.+..++ +.+++.+|+++++|.|..++....++
T Consensus 157 ~~~i~l-~i~~~~-~~Gv~Ga~iat~i~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~k~ll~~g~p~~~~~~~~~i 233 (416)
T PRK15099 157 LIGVAA-YYLCYR-LGGYEGALLGLALVPALVVLPAGIMLIRRGTIPLSYLKP-SWDNGLAGQLGKFTLMALITSVTLPV 233 (416)
T ss_pred HHHHHH-HHHHHH-HhcchHHHHHHHHHHHHHHHHHHHHHHHccceehHhhhc-cCCHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999887 444442 34999999999999999887777766654 211111111 23567789999999999999999999
Q ss_pred HHHHHHHHHh-cCCchhhHHHHHHHHHHHHH-HHHHHHHhhhhcc
Q 019922 291 YYRVLILMTG-NLQNAKIAVDALSICMSING-WELMIPLSFFAGT 333 (334)
Q Consensus 291 ~~~~~~~~~~-~~g~~~~~~aa~~i~~~i~~-~~~~~~~~~~~a~ 333 (334)
....++.+++ .+|. .++|.|+++.++.. +...++.+++++.
T Consensus 234 ~~~~~~~~l~~~~g~--~~vg~y~~a~~i~~~~~~~~~~~~~~a~ 276 (416)
T PRK15099 234 AYVMMRNLLAAHYSW--DEVGIWQGVSSISDAYLQFITASFSVYL 276 (416)
T ss_pred HHHHHHHHHHhcCCH--HHhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999985 7784 36789999999977 4478888888763
No 17
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.88 E-value=6.8e-20 Score=173.86 Aligned_cols=244 Identities=12% Similarity=0.136 Sum_probs=199.5
Q ss_pred HHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHHH
Q 019922 55 WHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQ 133 (334)
Q Consensus 55 ~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~ 133 (334)
.|-+.|.+++++...+.+++|+.+++| +|++++|+++.+.++..++......|++.+..+.++|+.|++|+++.++.++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~~~l~r~Lg~~~~G~~~~~~~~~~~~~~~~~~Gl~~a~~~~is~~~~~~~~~~~~~~~~ 81 (488)
T TIGR02900 2 LKGTFILTIANLITRILGFIFRIVLSRILGAEGVGLYGMAMPIYFLFITLTTGGLPVAISKFVAEASAKNDRKNIKKILK 81 (488)
T ss_pred hHhHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhhHHHHHHHHHHHHHHHHhCCcHHHHHHHHHHHHhccchhhHHHHHH
Confidence 467899999999999999999999999 7999999999999988865343456899999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHHH
Q 019922 134 RSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLL 212 (334)
Q Consensus 134 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~ 212 (334)
....+....+++..++ +.+.+++...++.+++. ..++++..+..++..+.....+++|+.+|.+..+..++++.+
T Consensus 82 ~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~i~~i 157 (488)
T TIGR02900 82 VSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERS----LYSLLVICPAMPFIALSSVLKGYFQGISNMKPPAYIQVIEQI 157 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhH----HHHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHHHHHHHHH
Confidence 9999999999777655 44677776766666543 246788899999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHh-----hccCchhHHHHHHHHHHHHHHHHHHHHHhc-CCC--CccCCCCHHhHhhHHHHHHHHHHHHHH
Q 019922 213 VHLLVTWLFVYK-----MQLGLIGTAITLSFSWWVLIFGMFGYVACG-GCP--RTWTGFSMEAFSDLWEFVKLSVASGVM 284 (334)
Q Consensus 213 ~~i~l~~~li~~-----~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~l~~~~p~~~~ 284 (334)
+++.++..++.. .++|+.|+++++.+++.+..++..++.+++ +.+ ..+.+..+.+++.+|++++.+.|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~~~~~p~~l~ 237 (488)
T TIGR02900 158 VRISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRKKSFSIRFPFFDYKSEGKALLFDLFSVSLPLTLS 237 (488)
T ss_pred HHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccCcchHHHHHHHHHHHHHHHHH
Confidence 988776666542 246788889999999998888877666544 222 112222234567899999999999999
Q ss_pred HHHHHHHHHHHHHHHhcC
Q 019922 285 LCLENWYYRVLILMTGNL 302 (334)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~ 302 (334)
.........+++.++++.
T Consensus 238 ~~~~~~~~~~d~~ii~~~ 255 (488)
T TIGR02900 238 RFIGSLLYFLETLLVPQR 255 (488)
T ss_pred HHHHHHHHHHHHHHHHHH
Confidence 999999999888877654
No 18
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.86 E-value=1.8e-18 Score=161.73 Aligned_cols=205 Identities=14% Similarity=0.131 Sum_probs=190.5
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhh
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYM 127 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~ 127 (334)
.+..|++++...|.+++.....+...+|+.+.+.+++.++++++.+.++.++....+..++++...|..|+...++|.++
T Consensus 194 ~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~vs~l~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~~ 273 (451)
T PF03023_consen 194 DPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGSVSALNYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWEE 273 (451)
T ss_pred ChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHH
Confidence 35689999999999999999999999999999999999999999999999986667788999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcC----CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhH
Q 019922 128 LGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLG----QPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (334)
Q Consensus 128 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (334)
.++..++.+.....+.+|..++ +.+++++.+++. .+.+..+....++++++++.|+..+...+...+.++||+|.
T Consensus 274 ~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~~~ 353 (451)
T PF03023_consen 274 FRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAEDTQLTASALRIYALGLPFYALNDLLSRVFYALGDTKT 353 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCcHh
Confidence 9999999999999999999766 559999998764 36666788899999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 203 IAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 203 ~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
++++++++.++|+++++++.. .+|..|.++++.++.++..+++.++++|+
T Consensus 354 ~~~~~~~~~~lni~l~~~l~~--~~g~~Glala~sl~~~i~~~~l~~~l~r~ 403 (451)
T PF03023_consen 354 PVRISVISVVLNIILSILLVP--FFGVAGLALATSLSAIISALLLYILLRRR 403 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999988 79999999999999999999998888776
No 19
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=99.85 E-value=1.4e-18 Score=162.27 Aligned_cols=200 Identities=16% Similarity=0.111 Sum_probs=168.2
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhh
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYM 127 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~ 127 (334)
++..|++++.+.|..++++.......+-+.+++++|++++|+++++.++.++. +.+..|++++.+++++|++|+||+|+
T Consensus 228 ~~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~G~~alAa~~I~~~i~~~~-~~~~~gl~~a~~~lvg~~~Ga~~~~~ 306 (441)
T PRK10367 228 RGNFRRLLALNRDIMLRSLLLQLCFGAITVLGARLGSDIIAVNAVLMTLLTFT-AYALDGFAYAVEAHSGQAYGARDGSQ 306 (441)
T ss_pred HHHHHHHHHhCchHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHcCCCHHH
Confidence 35789999999999999999999999999999999999999999999999984 78999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcc---hhhHH
Q 019922 128 LGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQL---KTMVI 203 (334)
Q Consensus 128 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g---~~~~~ 203 (334)
+++..+.+..++.+.+++..++ +.+++++..+|.+|+|+.+.+..++++..+..+.........+.++|.+ |++.+
T Consensus 307 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~g~lrg~dt~~~ 386 (441)
T PRK10367 307 LLDVWRAACRQSGIVALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCYLLDGMFIGATRAAEMRNS 386 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccchHHHHHH
Confidence 9999999999999999777665 5588999999999999999999999998876433224444444444444 59999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 204 AWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
+++++++..+ .++... .+|+.|+|++..+++.+..+++..+.+++
T Consensus 387 ~~~~~~~~~~----~~~~~~--~~g~~Gvw~a~~~~~~~~~i~~~~~~~~~ 431 (441)
T PRK10367 387 MAVAAAGFAL----TLLTLP--WLGNHGLWLALTVFLALRGLSLAAIWRRH 431 (441)
T ss_pred HHHHHHHHHH----HHHHHH--HcCchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999887543 112222 57999999999999999998887766554
No 20
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.82 E-value=1.5e-16 Score=147.46 Aligned_cols=238 Identities=15% Similarity=0.124 Sum_probs=204.0
Q ss_pred HHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhH
Q 019922 49 IESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYML 128 (334)
Q Consensus 49 ~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~ 128 (334)
...|++.+...|..++...+.+...+|+.+.+.+.+.+++.+.++..+.++..-.+..++++...|..||...++|.++.
T Consensus 229 ~~lk~~~~~~~p~~l~~sisQi~lli~~~iAS~l~~Gsis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~~~ 308 (518)
T COG0728 229 PGLKRFLKLMLPALLGVSISQINLLIDTAIASFLAEGSVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWPEF 308 (518)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChHHH
Confidence 68999999999999999999999999999999999999999999999999865688999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HhhHHHHHHcC----CCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHH
Q 019922 129 GVYMQRSWIVLFICCVLLLPLY-VFASPVLKLLG----QPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (334)
Q Consensus 129 ~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (334)
++..+++++++..+.+|...++ .+++|+...+. .+++....+...+..+.++.++..+..++...+++++|+|.+
T Consensus 309 ~~~l~~~i~l~lll~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FYAr~d~ktP 388 (518)
T COG0728 309 LKLLDWGLRLTLLLTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFYAREDTKTP 388 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHccCCCcC
Confidence 9999999999999999998774 49999997763 255566778889999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHH
Q 019922 204 AWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGV 283 (334)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~ 283 (334)
+++++++.++|+.+++++.. .+|..|.++++.++.++++.++++..+|+..... .+.|.... ..|..+-..+
T Consensus 389 ~~i~ii~~~~n~~l~~~l~~--~~~~~giala~s~a~~~~~~ll~~~l~k~~~~~~-----~~~~~~~~-~~k~~l~~~i 460 (518)
T COG0728 389 MKIAIISLVVNILLNLLLIP--PLGHVGLALATSLAAWVNALLLYYLLRKRLVYLP-----GRGWGLFL-ILKLLLASAI 460 (518)
T ss_pred hHHHHHHHHHHHHHHHHHHh--hccchHHHHHHHHHHHHHHHHHHHHHHHhcCCCc-----cchhhHHH-HHHHHHHHHH
Confidence 99999999999999977777 6899999999999999999888888887622211 22344444 5666666666
Q ss_pred HHHHHHHHHHH
Q 019922 284 MLCLENWYYRV 294 (334)
Q Consensus 284 ~~~~~~~~~~~ 294 (334)
+....+.....
T Consensus 461 ~~~~~~~~~~~ 471 (518)
T COG0728 461 MAAALLALLHL 471 (518)
T ss_pred HHHHHHHHHHH
Confidence 55544444333
No 21
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.82 E-value=3.9e-18 Score=161.88 Aligned_cols=204 Identities=15% Similarity=0.123 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cCh------hHHHHH----HHHHHHHHHHHHHHHHHHHHhHHH
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGD------LELAAI----SIANTVVVAFNFGLLLGMASALET 114 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~------~~~a~~----~i~~~~~~~~~~~~~~~i~~~~~~ 114 (334)
.+++..|+++++++|..++++...+...+|+.++++ +++ ++.+.+ +++.++..+. ..+..+++.+..|
T Consensus 219 ~~~~~~k~l~~~~~p~~l~~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~-~~~~~~l~~~~~p 297 (488)
T TIGR02900 219 EGKALLFDLFSVSLPLTLSRFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFP-AVITSSLSTALVP 297 (488)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhH-HHHHHHHHHHHHH
Confidence 345688999999999999999999999999999987 422 122232 3445566654 5677899999999
Q ss_pred HHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHH
Q 019922 115 LCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRF 193 (334)
Q Consensus 115 ~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~ 193 (334)
.++++.|++|+++.++..++...+...+++|..++ ..++++++.++..++ .+..++++++++.++..+.....+.
T Consensus 298 ~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~----~~~~~l~i~~~~~~~~~~~~~~~~~ 373 (488)
T TIGR02900 298 DISEAMAKKNYSSIEKRINQAIKISLLLGLITTVILLVIPDELGALFYGRP----DAGNFIRVLAPSFPFLYFSAPLQSI 373 (488)
T ss_pred HHHHHHHcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC----chHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999887766 558888888876543 3567899999999999999999999
Q ss_pred HHHcchhhHHHHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 194 LQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 194 l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
+++.||+|..++.++++.++|++++++++....+|+.|+++++.+++.+..++..++.+|.
T Consensus 374 l~~~g~~~~~~~~~~~~~i~~i~l~~~l~~~~~~G~~Gaaia~~i~~~~~~~~~~~~~~~~ 434 (488)
T TIGR02900 374 LQGLGKQKVALRNSLIGAIVKIILLFVLTSIPSINIYGYAITFIITSVLVTILNLAEIKKN 434 (488)
T ss_pred HHhcCcchHHHHHHHHHHHHHHHHHHHHHhccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998832378999999999999999998888877654
No 22
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.80 E-value=3.2e-20 Score=149.81 Aligned_cols=160 Identities=25% Similarity=0.404 Sum_probs=152.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHH
Q 019922 60 PTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVL 139 (334)
Q Consensus 60 p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 139 (334)
|..+++++..+...+|+.+++++|++++++++++.++.++. ..+..|++.+..+.+||++|++|+|++++.+++.+.+.
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~~~~a~~~i~~~~~~~~-~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~~ 79 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGPEALAAYGIASSIFSIL-FMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLLS 79 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTTCCCCHCCHHHHHHHHH-HHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHHHH-hhhcccccccccceeecccccccccccccccccccccc
Confidence 88999999999999999999999999999999999999985 67999999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHH-HHHHHH
Q 019922 140 FICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASL-LVHLLV 217 (334)
Q Consensus 140 ~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~-~~~i~l 217 (334)
.+++++..++ +.+.+++..+++.|+++.+.+..|+++..++.++..+.....+++++.||++..++.++.+. ++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l 159 (162)
T PF01554_consen 80 LIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINIPL 159 (162)
T ss_dssp HHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHHHH
T ss_pred hhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHHhH
Confidence 9999888766 66899999999999999999999999999999999999999999999999999999999999 999999
Q ss_pred HHH
Q 019922 218 TWL 220 (334)
Q Consensus 218 ~~~ 220 (334)
+|+
T Consensus 160 ~yl 162 (162)
T PF01554_consen 160 AYL 162 (162)
T ss_dssp HHH
T ss_pred HhC
Confidence 885
No 23
>PRK15099 O-antigen translocase; Provisional
Probab=99.78 E-value=1.5e-16 Score=147.91 Aligned_cols=202 Identities=7% Similarity=-0.047 Sum_probs=174.6
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCc
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKK 124 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~ 124 (334)
.+++..|++++++.|..++++...+...+|+.++++ +|++++|.|+.+.++.+.+...+..+++++..|.++++ +|
T Consensus 209 ~~~~~~k~ll~~g~p~~~~~~~~~i~~~~~~~~l~~~~g~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~~ 285 (416)
T PRK15099 209 WDNGLAGQLGKFTLMALITSVTLPVAYVMMRNLLAAHYSWDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---TE 285 (416)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CC
Confidence 346788999999999999999999999999999985 89999999999999988544678899999999999995 67
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHH
Q 019922 125 YYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (334)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (334)
+++.++..++.......++++..+. ++++++++.++.+++ .+.+.+++++++++.++......+...+.+.++++..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~~~ 363 (416)
T PRK15099 286 KRDITREIVKALKFVLPAVAAASFTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLRFY 363 (416)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 7889999999999998888777665 468999998887654 2346778999999999888888888888899999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 204 AWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
....+...++++++++++++ .+|..|+++++.+++.+..++..+...++
T Consensus 364 ~~~~~~~~~l~i~l~~~li~--~~G~~G~a~a~~is~~~~~~~~~~~~~~~ 412 (416)
T PRK15099 364 ILAEVSQFTLLTGFAHWLIP--LHGALGAAQAYMATYIVYFSLCCGVFLLY 412 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHH--HhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999988999999999998 68999999999999999988776655543
No 24
>PRK10459 colanic acid exporter; Provisional
Probab=99.78 E-value=2.9e-16 Score=149.19 Aligned_cols=201 Identities=14% Similarity=0.012 Sum_probs=174.1
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchh
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYY 126 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~ 126 (334)
++..|++++++.|...+++...+...+|+.++++ +|++++|.|+.+.++.+.....+...++....|..++. ++|++
T Consensus 203 ~~~~k~ll~~~~~~~~~~~~~~~~~~~d~~~lg~~lg~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~~ 280 (492)
T PRK10459 203 LASVKPNLSFGAWQTAERIINYLNTNIDTILIGRILGAEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDTE 280 (492)
T ss_pred HHHHHHHHhhhHHHHHHHHHHHHHhcCchhhhhHhhchHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCHH
Confidence 4678999999999999999999999999999999 79999999999999988654455556777888999886 56888
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHH
Q 019922 127 MLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAW 205 (334)
Q Consensus 127 ~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 205 (334)
+.++.+++...+...+++|+.++ ..++++++.++.+++ ...+...+++++++..+..+.......+++.||+|..++
T Consensus 281 ~~~~~~~~~~~~~~~~~~p~~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~~ 358 (492)
T PRK10459 281 KLRVGFLKLLSVLGIINFPLLLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSFK 358 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhHH
Confidence 99999999999999999998776 458888887776544 355788999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 206 VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 206 ~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
.+++..+++++..+.+.. .+|+.|+++++.+++.+...+..++..|+
T Consensus 359 ~~~~~~~~~i~~~~~~~~--~~G~~g~a~a~~i~~~~~~~~~~~~~~~~ 405 (492)
T PRK10459 359 WNVFKTFLFIPAIVIGGQ--LAGLIGVALGFLLVQIINTILSYFLMIKP 405 (492)
T ss_pred HHHHHHHHHHHHHHHHHh--hccHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999988888888777776 68999999999999999888887777554
No 25
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.72 E-value=3.4e-14 Score=133.03 Aligned_cols=243 Identities=19% Similarity=0.171 Sum_probs=195.5
Q ss_pred cChh-HHHHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHH
Q 019922 82 LGDL-ELAAISIANTVVVAFNFGLL-LGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLK 158 (334)
Q Consensus 82 ~g~~-~~a~~~i~~~~~~~~~~~~~-~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 158 (334)
+|.. +..+|.++.++.+.+...+. .++..+..|..++.. ++++|+.++..++...+..+..+.+.++ +.+++++..
T Consensus 5 fG~s~~~Daf~~A~~ip~~l~~l~~~gal~~~~IP~~~~~~-~~~~~~~~~f~~~~~~~~~~~~~~l~~l~~lfa~~iv~ 83 (451)
T PF03023_consen 5 FGASAEADAFFVAFTIPNFLRSLLAGGALSAAFIPVFSKAR-EKGEEEARRFISTLLTILLIISLLLTLLGILFAPPIVR 83 (451)
T ss_pred hcCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5654 56799999999997644443 468999999999999 8889999999998888877777655544 668899888
Q ss_pred Hc--CCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHHHHHHHHHHHHHHhhccC---chhHH
Q 019922 159 LL--GQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLG---LIGTA 233 (334)
Q Consensus 159 ~~--~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~g---~~G~~ 233 (334)
.+ +.+++..+.+..++++..+..++..+..++.+++++++|...+....++.++.-++..+++.. .+| +.+.+
T Consensus 84 ~la~g~~~~~~~la~~l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~~~l~~N~~~I~~~~~~~~--~~~~~~i~~la 161 (451)
T PF03023_consen 84 LLAPGFSPETIELAVQLLRILAPSILFIGLSSIFSAILNAHRRFLIPALSPLLFNLSIILSLLLLSN--SWGQENIYALA 161 (451)
T ss_pred HHCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHHHHHHHHHHHHHHHHHHHH--hcCchHHHHHH
Confidence 77 567888899999999999999999999999999999999999999998888765554444444 567 89999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchhhHHHHHH
Q 019922 234 ITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYRVLILMTGNLQNAKIAVDALS 313 (334)
Q Consensus 234 ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~aa~~ 313 (334)
+|..++.++..++.+.+.+|.+.+.+.. ++ ...+.+|++++...|..+.....++...+.+.+++.++++. +++++
T Consensus 162 ~g~~~g~~~~~l~~l~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~--vs~l~ 237 (451)
T PF03023_consen 162 WGVLIGAIIQFLIQLPYLRRFGFRFRPK-FD-WRDPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGS--VSALN 237 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCccccc-CC-CCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccH--HHHHH
Confidence 9999999999999888888764442211 11 12256899999999999999999999999999999999775 55999
Q ss_pred HHHHHHHHHH-HHHHhhhh
Q 019922 314 ICMSINGWEL-MIPLSFFA 331 (334)
Q Consensus 314 i~~~i~~~~~-~~~~~~~~ 331 (334)
.+.++.++.. .+..++++
T Consensus 238 YA~~l~~lp~~i~~~~i~t 256 (451)
T PF03023_consen 238 YAQRLYQLPLGIFAVSIST 256 (451)
T ss_pred HHHHHHHHHHHHHHHHHHH
Confidence 9999988765 44445443
No 26
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.71 E-value=9e-15 Score=138.59 Aligned_cols=187 Identities=20% Similarity=0.236 Sum_probs=170.2
Q ss_pred HHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 47 FWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 47 ~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
.++..|+.++.++|..++.+...+.+.+|+.++++ +|++++|.|+.+.++.... ..+..+++....|..+++..++|.
T Consensus 208 ~~~~~~~~l~~~~p~~~~~~~~~l~~~~D~~~i~~~l~~~~vG~Y~~a~~i~~~~-~~~~~~l~~~l~P~~s~~~~~~~~ 286 (480)
T COG2244 208 SLALLKELLRFGLPLLLSSLLNFLFTNIDTLLLGLFLGPAQVGIYSAAQRLVSLL-LIVASALNRVLFPALSRAYAEGDR 286 (480)
T ss_pred hhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHhhhhHheecccccHHHHHH-HHHHHHHHHHHHHHHHHHHHcCcH
Confidence 46899999999999999999999999999999999 7999999999888887774 678889999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHH
Q 019922 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (334)
++.++..++...+...+++|..++ ..++++++..+.+++.. .+...+++++++.++..+.......+++.||++..+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~i~~~fg~~~~--~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~~~~ 364 (480)
T COG2244 287 KALKKLLRQSLKLLLLISIPALLGLLLLAPPIITLLFGEKYA--SAAPILQLLALAGLFLSLVSLTSSLLQALGKQRLLL 364 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhheeecCCccc--chhHHHHHHHHHHHHHHHHHHHHHHHHHcCcchhhH
Confidence 999999999999999999998776 45888888877655432 277789999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHH
Q 019922 205 WVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFS 239 (334)
Q Consensus 205 ~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~ 239 (334)
+.+.++.++|++++++++. .+|+.|+++++ .+
T Consensus 365 ~~~~~~~i~~~~l~~~li~--~~g~~g~~~a~-~~ 396 (480)
T COG2244 365 LISLISALLNLILNLLLIP--RFGLIGAAIAT-AS 396 (480)
T ss_pred HHHHHHHHHHHHHHhHHHH--hhhhhhHHHHH-HH
Confidence 9999999999999999998 78999999999 44
No 27
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.66 E-value=1.2e-12 Score=121.76 Aligned_cols=274 Identities=12% Similarity=0.071 Sum_probs=212.0
Q ss_pred HHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChh-HHHHHHHHHHHHHHHHHHHHH-HHHHhHHHHHHhhhccCchhh
Q 019922 51 SKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDL-ELAAISIANTVVVAFNFGLLL-GMASALETLCGQAFGGKKYYM 127 (334)
Q Consensus 51 ~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~-~~a~~~i~~~~~~~~~~~~~~-~i~~~~~~~~s~~~g~~~~~~ 127 (334)
.+.++|.++-....++++.+.+++...+++. +|+. ...++.++.++.+++--.+.. +++++..|...++..++++|+
T Consensus 6 ~~sllks~~~vs~~Tl~SRi~G~vRd~~iA~~fGa~~~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~~~~~ 85 (518)
T COG0728 6 KMSLLKSLIIVSSATLLSRILGFVRDVLIAAAFGAGAAADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKEGEEA 85 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcchhhH
Confidence 3456778888888999999999998888888 7985 667999999999975444444 458899999999998887778
Q ss_pred HHHHHHHHHHHHHHHHHHH-HHHHHhhHHHHHHc-CC--CHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHH
Q 019922 128 LGVYMQRSWIVLFICCVLL-LPLYVFASPVLKLL-GQ--PDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVI 203 (334)
Q Consensus 128 ~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 203 (334)
.++..+........+.+.+ .+...+.+++.+.. .. |++....+....++..|..++..+.....+.+++.+|...+
T Consensus 86 ~~~f~~~v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~F~~~ 165 (518)
T COG0728 86 ARFFSRLVTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNRFFIP 165 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeechh
Confidence 8777777664555555444 44566777777443 33 34444468888999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcC--CCCccCCCCHHhHhhHHHHHHHHHHH
Q 019922 204 AWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGG--CPRTWTGFSMEAFSDLWEFVKLSVAS 281 (334)
Q Consensus 204 ~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~p~ 281 (334)
.+..+.-++.-+.....+..+......+.++++.++-+++.++.+..++|.+ ++++|. + + -+.+|++++.-.|.
T Consensus 166 a~aPvl~Nv~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~g~~~~p~~~-~--~-~~~lk~~~~~~~p~ 241 (518)
T COG0728 166 AFAPVLLNVSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKAGLLIKPRFG-F--K-DPGLKRFLKLMLPA 241 (518)
T ss_pred hhhHHHHHHHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHcccccCCCCC-C--C-chhHHHHHHHHHHH
Confidence 9999888877665555555543224788999999999999999999999873 333322 1 1 15699999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHH-HHHHhhh
Q 019922 282 GVMLCLENWYYRVLILMTGNLQNAKIAVDALSICMSINGWEL-MIPLSFF 330 (334)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~-~~~~~~~ 330 (334)
.+.....++...+++.+++.+.++. ++.++.+.++.++-. .+..+++
T Consensus 242 ~l~~sisQi~lli~~~iAS~l~~Gs--is~l~YA~rl~qlPlGifgvai~ 289 (518)
T COG0728 242 LLGVSISQINLLIDTAIASFLAEGS--VSWLYYADRLYQLPLGIFGVALS 289 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccc--HHHHHHHHHHHHhhHHHHHHHHH
Confidence 9999999999999999999998665 447888888776544 4444443
No 28
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=99.66 E-value=1.8e-12 Score=113.12 Aligned_cols=262 Identities=18% Similarity=0.165 Sum_probs=191.1
Q ss_pred HHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHHH
Q 019922 55 WHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQ 133 (334)
Q Consensus 55 ~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~ 133 (334)
+|-+......++...+.+++-..+++| +|+++.|.++....+.+++......|++.+....+++...+ .++.+....
T Consensus 2 ~k~~~~~~~~~~~~~~~~~~~~~il~r~l~~~~~G~~~~~~~~~~~~~~~~~~G~~~~~~r~~~~~~~~--~~~~~~~~~ 79 (273)
T PF01943_consen 2 LKNSLWLFLSNILSALIGFITIPILARYLGPEEYGIYSLALSIVSLLSILADLGLSQAIVRFIAEYKDK--KELRSAYFS 79 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHhhhh--HHHHHHHHH
Confidence 466777888999999999999999999 89999999999999988765555788888888888876432 234444444
Q ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHHHH
Q 019922 134 RSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLV 213 (334)
Q Consensus 134 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~ 213 (334)
.........++...+...... .+..++. .. .+........++.........++++.++.+.....++...+.
T Consensus 80 ~~~~~~~~~~~i~~~~~~~~~----~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (273)
T PF01943_consen 80 SVLFLLLIFSLIFLLILLIAS----FFGNPSL-SL---ILIILALLILILSSLSSVFSGLLQGLQRFKYIAISNIISSLL 151 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHH----HcCCchH-HH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 444433333333333222222 3333332 11 122222222256788888999999999999999999999888
Q ss_pred HHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHHHHHHHHHHHH
Q 019922 214 HLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYR 293 (334)
Q Consensus 214 ~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~ 293 (334)
..++..+++.. +.++.+..++..++..+..++..++.+|+. +.+ ....+++..|++++.+.|..+......+...
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (273)
T PF01943_consen 152 SLLLILLLLFL-GSSLWGFLLGLVISSLVSLIISLFYLRRKL-RPR---FSFFSKKFFKEILRFGLPLFLSSLLSWLYSQ 226 (273)
T ss_pred HHHHHHHHHHH-hhhHHHHHHHHHHHHHHHHHHHHHHHHHHH-ccc---ccccchHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 87777666654 445899999999999988888887777652 121 1122367899999999999999999999999
Q ss_pred HHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhc
Q 019922 294 VLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAG 332 (334)
Q Consensus 294 ~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a 332 (334)
.+..+++.+... .++|.|+++.++......++.++.+.
T Consensus 227 ~d~~ii~~~~g~-~~vg~Y~~a~~l~~~~~~~~~~~~~~ 264 (273)
T PF01943_consen 227 IDRLIIGYFLGP-EAVGIYSVAYRLASAISFLLSSISTV 264 (273)
T ss_pred hHHHHHHHhCCH-HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999998543 35789999999999999998887663
No 29
>PRK10459 colanic acid exporter; Provisional
Probab=99.57 E-value=7.2e-12 Score=119.16 Aligned_cols=252 Identities=6% Similarity=0.031 Sum_probs=182.4
Q ss_pred HHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHH
Q 019922 51 SKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLG 129 (334)
Q Consensus 51 ~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~ 129 (334)
.++..+-+....++++...+.+++...+++| +|+++.|.++.+..+..++......|++.+. .|. +| +.+
T Consensus 4 ~~~~~~g~~w~~~~~~~~~~~~~i~~~ilaR~L~p~~~G~~~~~~~~~~~~~~~~~~Gl~~ai----i~~---~~--~~~ 74 (492)
T PRK10459 4 REKTISGAKWTAISTVIIIGLQLVQLTVLARILDNHQFGLLTMSLVIIGFADTLSDMGIGASI----IQR---QD--ISH 74 (492)
T ss_pred HHHHHccccHHHHHHHHHHHHHHHHHHHHHHhCCHHHccHHHHHHHHHHHHHHHHHcCHHHHH----Hhc---cc--CCH
Confidence 3556777888899999999999999999999 8999999999999998875444555666653 221 11 112
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-hhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHH
Q 019922 130 VYMQRSWIVLFICCVLLLPLYV-FASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSL 208 (334)
Q Consensus 130 ~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~ 208 (334)
+.......+....++.+.++.+ +.+++...+ ++++. ...+++..+..++..+.....+.+++.++.+.......
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~~ 149 (492)
T PRK10459 75 LQLSTLYWLNVGLGIVVFVLVFLLSPLIADFY-HNPEL----APLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIEI 149 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHc-CChhh----HHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHHH
Confidence 3445555666666655554444 455554444 44443 34677788888888888889999999999999998888
Q ss_pred HHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHHHHHHH
Q 019922 209 ASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLE 288 (334)
Q Consensus 209 ~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~ 288 (334)
+..+...++...+... ++|..+..++..+++.+..++..+.. ++++++++ ..+++..|++++++.|........
T Consensus 150 ~~~i~~~~~~i~~~~~-~~g~~~l~~~~~~~~~~~~l~~~~~~-~~~~~~~~----~~~~~~~k~ll~~~~~~~~~~~~~ 223 (492)
T PRK10459 150 SAVVAGFTFAVVSAFF-WPGALAAILGYLVNSSVRTLLFGYFG-RKIYRPAL----HFSLASVKPNLSFGAWQTAERIIN 223 (492)
T ss_pred HHHHHHHHHHHHHHHH-CCcHHHHHHHHHHHHHHHHHHHHHHh-cccCCccc----eecHHHHHHHHhhhHHHHHHHHHH
Confidence 8887777766665543 78999999999999987766543333 22333221 123466899999999999999999
Q ss_pred HHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHH
Q 019922 289 NWYYRVLILMTGNLQNAKIAVDALSICMSINGWEL 323 (334)
Q Consensus 289 ~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~ 323 (334)
++...++..+++.+.. +.+++.|+.+.++.+...
T Consensus 224 ~~~~~~d~~~lg~~lg-~~~vG~Y~~A~~l~~~~~ 257 (492)
T PRK10459 224 YLNTNIDTILIGRILG-AEVLGGYNLAYNVATVPP 257 (492)
T ss_pred HHHhcCchhhhhHhhc-hHhhhhHHHHHHHHHHHH
Confidence 9999999998887743 235779999998877543
No 30
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.47 E-value=2.6e-12 Score=116.33 Aligned_cols=131 Identities=21% Similarity=0.293 Sum_probs=119.5
Q ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 46 RFWIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 46 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
.+++..|+++++++|.+++++...+...+|+.+++++|++++++|+++.++.++. ..+..+++.+..|.++++++++|.
T Consensus 210 ~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~~~i~~~~g~~~v~~~~~a~~~~~~~-~~~~~~~~~a~~~~~~~~~~~~~~ 288 (342)
T TIGR00797 210 PDWEVLKRLLKLGLPIAFRVILESLSFALLALLVARLGSIALAAHQIALNVESLL-FMPAFGFGIAVSILVGQALGAGDP 288 (342)
T ss_pred CCHHHHHHHHHhCchHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCH
Confidence 3456899999999999999999999999999999999999999999999998874 678899999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHcCCCHHHHHHHHHHHHHH
Q 019922 126 YMLGVYMQRSWIVLFICCVLLLPL-YVFASPVLKLLGQPDDVAELSGVVSLWL 177 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~i~ 177 (334)
++.++..+++..+...++++..++ +.+++++.+++.+|+++.+.+..++++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T TIGR00797 289 KRAKEVARVALKLSLLLGLVLAIILILFREFIARLFTNDPEVLELAAIYLIFV 341 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999888766 5588999999999999999988888764
No 31
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=99.45 E-value=1.3e-09 Score=94.01 Aligned_cols=237 Identities=16% Similarity=0.158 Sum_probs=162.8
Q ss_pred HHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHH
Q 019922 71 MFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPL 149 (334)
Q Consensus 71 ~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 149 (334)
.+++-..+++| +|+++.|.++....+..++......|+...... . .++|+++.++..+.........++...++
T Consensus 3 ~~f~~~~~lar~l~~~~~G~~~~~~s~~~~~~~~~~~g~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (251)
T PF13440_consen 3 INFLFLILLARYLGPEDFGIYALIFSIVSILSIVASLGLRQSLVR----S-AARDKQDIRSLLRFSLLVSLLLAVILAIL 77 (251)
T ss_pred HHHHHHHHHHHHCCHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHH----h-hccCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45667788899 899999999999999887544345555554333 2 23455566666555554444444333322
Q ss_pred HHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHHHHHHHHHHHHHHhhccCc
Q 019922 150 YVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGL 229 (334)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~ 229 (334)
...+...+ .+++. ..++....+..++..+.....+.+++.+|.+.......+..+....+..++... +.+.
T Consensus 78 ---~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 148 (251)
T PF13440_consen 78 ---AILIAYFF-GDPEL----FWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLRLLLLVLLLYL-GLNL 148 (251)
T ss_pred ---HHHHHHHh-CChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHHH-HhhH
Confidence 11111233 33322 235566777888889999999999999999999999999988775554444443 4588
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-CCchhhH
Q 019922 230 IGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCLENWYYRVLILMTGN-LQNAKIA 308 (334)
Q Consensus 230 ~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~-~g~~~~~ 308 (334)
.+..++..++..+..++..+..+++ .+. .. +.+..| .++.+.|........+....++..+++. +|. .+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~~ 218 (251)
T PF13440_consen 149 WSILLAFIISALLALLISFYLLRRK-LRL--SF----KFSWRR-LLKYGLPFSLSSLLSWLLSQIDRLLIGYFLGP--EA 218 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccc-cCC--Cc----hhhHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCH--HH
Confidence 8999999999888776665533322 111 11 122234 7899999999999999999999999999 654 35
Q ss_pred HHHHHHHHHHHHHHH-HHHHhhhh
Q 019922 309 VDALSICMSINGWEL-MIPLSFFA 331 (334)
Q Consensus 309 ~aa~~i~~~i~~~~~-~~~~~~~~ 331 (334)
+|.|+++.++..... ++..++++
T Consensus 219 ~g~y~~a~~l~~~~~~~~~~~i~~ 242 (251)
T PF13440_consen 219 VGIYSVAQRLASLPASLLSSAISS 242 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHH
Confidence 779999999999777 78777765
No 32
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.36 E-value=4.3e-10 Score=106.65 Aligned_cols=267 Identities=13% Similarity=0.087 Sum_probs=184.9
Q ss_pred HHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhH
Q 019922 50 ESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYML 128 (334)
Q Consensus 50 ~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~ 128 (334)
..+++.|-+.....+++...+..++....++| +|+++.|.++.+..+..++......|+..+....++++.+++++...
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lar~lg~~~~G~~~~~~~~~~~~~~i~~~G~~~ai~r~ia~~~~~~~~~~~ 83 (480)
T COG2244 4 LKKKLIKGALWLLLGTLISALLGLITIPLLARLLGPEGFGLYALALAIIGLFSILADFGLPAAITREIAEYREKGEYLLL 83 (480)
T ss_pred HHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHHhCcccceeeehHHHHHHHHHHHHHcCCcHHHHHHHHHhhcccHHHHH
Confidence 45677888888899999999999999999999 89999999999999999865555678888888888887766655555
Q ss_pred HHH-HHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHH
Q 019922 129 GVY-MQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVS 207 (334)
Q Consensus 129 ~~~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~ 207 (334)
... ....+......+++......+..+. ++ .....+++..++.+.........+.+|+.++.+......
T Consensus 84 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (480)
T COG2244 84 ILLSVLLLLLLALILLLLLLLIAYLLAPI------DP----VLALLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALSI 153 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhccc------Ch----hhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhHH
Confidence 554 4444444444444333333332222 22 233356888999999999999999999999999999984
Q ss_pred HHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhcCCCCccCCCCHHhHhhHHHHHHHHHHHHHHHHH
Q 019922 208 LASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACGGCPRTWTGFSMEAFSDLWEFVKLSVASGVMLCL 287 (334)
Q Consensus 208 ~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~ 287 (334)
+.. ..-+...+.+. ........++...+..........+..+++.+.....+ +..++..|+.++.++|.......
T Consensus 154 ~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~p~~~~~~~ 228 (480)
T COG2244 154 VSS-IFLLAAVFALL---FAALGLAVWALVLGAVVSLLVLLILLGKKKRGLKRPIL-RFSLALLKELLRFGLPLLLSSLL 228 (480)
T ss_pred HHH-HHHHHHHHHHH---HHhhhHHHHHHHHHHHHHHHHHHHHHHHhhhhcccccc-CchhHHHHHHHHHhhHHHHHHHH
Confidence 444 11122222222 13455556666666665555555555322111111111 11467899999999999999999
Q ss_pred HHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHHHHHHhhhhc
Q 019922 288 ENWYYRVLILMTGNLQNAKIAVDALSICMSINGWELMIPLSFFAG 332 (334)
Q Consensus 288 ~~~~~~~~~~~~~~~g~~~~~~aa~~i~~~i~~~~~~~~~~~~~a 332 (334)
..+...+++.+++.+-. +..++.|+.+.++......+..+++.+
T Consensus 229 ~~l~~~~D~~~i~~~l~-~~~vG~Y~~a~~i~~~~~~~~~~l~~~ 272 (480)
T COG2244 229 NFLFTNIDTLLLGLFLG-PAQVGIYSAAQRLVSLLLIVASALNRV 272 (480)
T ss_pred HHHHHHHHHHHHHHHhh-hhHheecccccHHHHHHHHHHHHHHHH
Confidence 99999999999988843 335678998888888887777776653
No 33
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.25 E-value=1.2e-11 Score=115.51 Aligned_cols=206 Identities=16% Similarity=0.097 Sum_probs=183.0
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccCh--hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGD--LELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~--~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
.+.+++++++++|..+...++.-...+-....|.++. .++++.++....... .+.+..+++.+..+.+++.+|++|.
T Consensus 243 ~~~~~~~~~lai~s~~miclE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~-~~~~~~~~~~a~strv~neLGag~p 321 (473)
T KOG1347|consen 243 FDSWGPFFALAIPSAVMICLEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGW-HLMIPGAFSAAVSTRVSNELGAGKP 321 (473)
T ss_pred hhhHHHHHHHhhcchheeHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHH-HHHHhhhhhhhHHHHHHHHHcCCCh
Confidence 7889999999999999999999999999999999864 688999999888887 4677889999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHH-HHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHH
Q 019922 126 YMLGVYMQRSWIVLFICCVLLL-PLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (334)
+++|.....+...++..++... ..+...+.+...|+.|+++.+...+..+++++..++...+.++.+..+|.|+.+...
T Consensus 322 ~~ar~~~~v~~~~~~~~g~~~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~Gva~g~g~q~~ga 401 (473)
T KOG1347|consen 322 KRARVSAKVALQTSVAIGASLGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSGVARGSGWQQIGA 401 (473)
T ss_pred hhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhheEEeeccccceE
Confidence 9999999999999988886555 456688888899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHH-HHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 205 WVSLASL-LVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 205 ~~~~~~~-~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
++++... ++.+++...+-+..++|..|.|++...+..+....+.....+.
T Consensus 402 ~vnl~~yyl~G~p~g~~l~~~~~~g~~glw~G~~~~~~~~~~~l~~~~~~t 452 (473)
T KOG1347|consen 402 VINLVAYYLVGAPVGLYLGFFTKFGVKGLWIGILLGFSVQTLVLAIVTART 452 (473)
T ss_pred EEeeeeeeEecCcceeEEEEEEecCceEEEeehHHHHHHHHHHHHHheeec
Confidence 9998888 7888888888877789999999999999776666666555544
No 34
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=98.98 E-value=2.5e-06 Score=73.61 Aligned_cols=248 Identities=15% Similarity=0.123 Sum_probs=160.7
Q ss_pred HHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccC--h-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch
Q 019922 49 IESKKLWHIVGPTIFSRMASYSMFVITQAFAGHLG--D-LELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY 125 (334)
Q Consensus 49 ~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g--~-~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~ 125 (334)
...+++.++-+|..++.+...+.-.+.+..+++-. + +.+|+|+++..+.-++ -.+...+-.. +-.++++++
T Consensus 8 ~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~-~sp~~~~~~i-----gl~~V~s~r 81 (345)
T PF07260_consen 8 TSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFF-ASPLSMFHHI-----GLVFVNSKR 81 (345)
T ss_pred chHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHH-hChhhhhHHH-----HHHHhcchh
Confidence 46778899999999999999999888888888732 2 3589999999987664 4455444444 334444443
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHH-HH-hhHHHH-HHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhH
Q 019922 126 YMLGVYMQRSWIVLFICCVLLLPL-YV-FASPVL-KLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMV 202 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~~~~-~~-~~~~~~-~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~ 202 (334)
++.+ ........+.+..+...++ +- +...++ ..++.++++.+.+...+.++.+-.++.++....++++.-.+++..
T Consensus 82 srr~-~vl~~~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~s~i 160 (345)
T PF07260_consen 82 SRRK-AVLCMAVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRHSWI 160 (345)
T ss_pred hhHH-HHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhccceeE
Confidence 3222 2222222222222222233 33 444444 567889999999999999999999999999999999998888888
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhccCc-hhHHHHHHH---HHH-HHHHHHHHHHHhc-CCCCccCCCCHHhHhhHHHHHH
Q 019922 203 IAWVSLASLLVHLLVTWLFVYKMQLGL-IGTAITLSF---SWW-VLIFGMFGYVACG-GCPRTWTGFSMEAFSDLWEFVK 276 (334)
Q Consensus 203 ~~~~~~~~~~~~i~l~~~li~~~~~g~-~G~~ia~~i---~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~ 276 (334)
....++...+..+++..+++.. ++.. .++++.... +.. -..++.+.|.+.- +..+...+...++...++++++
T Consensus 161 V~~aSI~~v~~qvV~v~~ll~~-~l~~~~pllipil~~y~g~~vr~t~v~LGy~~~i~~~~p~~~~~~~~~~~tl~~~l~ 239 (345)
T PF07260_consen 161 VGSASIADVIAQVVLVAILLSM-HLEPQDPLLIPILALYAGIAVRFTIVCLGYYQSIHDIIPQLSGLEKGDSATLQRMLK 239 (345)
T ss_pred eehHHHHHHHHHHHHHHHHHcc-ccCccccHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhccccCCcccCCChhHHHHHH
Confidence 7777777776666666566632 2222 222222211 111 1122222333222 3333333333455578999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhc-CCc
Q 019922 277 LSVASGVMLCLENWYYRVLILMTGN-LQN 304 (334)
Q Consensus 277 ~~~p~~~~~~~~~~~~~~~~~~~~~-~g~ 304 (334)
+..|.+........+--+.+.++++ +|.
T Consensus 240 F~~PL~~~~~tq~~SrplVnl~vsR~l~g 268 (345)
T PF07260_consen 240 FWWPLALVLATQRISRPLVNLFVSRDLSG 268 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhccCC
Confidence 9999999999999999999999999 543
No 35
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=98.95 E-value=1.7e-07 Score=73.85 Aligned_cols=79 Identities=22% Similarity=0.244 Sum_probs=74.8
Q ss_pred HHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHh
Q 019922 174 SLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVAC 253 (334)
Q Consensus 174 l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~ 253 (334)
+++++++.++..+....++.+++.||+|..++.++++.++|+++++++++ ++|..|+++|+.+++.+..++..++.+|
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li~--~~G~~Gaa~a~~i~~~~~~~~~~~~~~k 79 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILIP--RFGIYGAAIATAISEIVSFILNLWYVRK 79 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHH--HHHHhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999987 7999999999999999999888888877
Q ss_pred c
Q 019922 254 G 254 (334)
Q Consensus 254 ~ 254 (334)
+
T Consensus 80 ~ 80 (146)
T PF14667_consen 80 K 80 (146)
T ss_pred H
Confidence 6
No 36
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.75 E-value=2.4e-06 Score=81.34 Aligned_cols=203 Identities=8% Similarity=-0.007 Sum_probs=162.5
Q ss_pred HHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc--c-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCch--
Q 019922 51 SKKLWHIVGPTIFSRMASYSMFVITQAFAGH--L-GDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKY-- 125 (334)
Q Consensus 51 ~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~--~-g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~-- 125 (334)
-++.++++.....+.+.-.+.+--|++++.. + ..++.|.|+++.++-++++-.+...+--+.-...++...+++.
T Consensus 252 d~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~l~~~~~~~ 331 (549)
T PF04506_consen 252 DRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFEDQGVYALVSNYGSLVARLLFQPIEESSRLYFSKLLSRDNSKK 331 (549)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHHhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHHhcccCchh
Confidence 4677888999999999999999999999998 4 7789999999999999878888889999888888888765533
Q ss_pred -------hhHHHHHHHHHHHHHHHHHHH-HHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHc
Q 019922 126 -------YMLGVYMQRSWIVLFICCVLL-LPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQ 197 (334)
Q Consensus 126 -------~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~ 197 (334)
++..+.+...+++...+++.+ ..+...++.++.+++++.-....+...++.++...|+.+++.+.-+++++.
T Consensus 332 ~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi~EaF~~s~ 411 (549)
T PF04506_consen 332 KQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGITEAFVFSV 411 (549)
T ss_pred hccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccHHHHHHHHh
Confidence 345566777777777777544 444667777777776544444456778999999999999999999999998
Q ss_pred chhhHHHH---HHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 198 LKTMVIAW---VSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 198 g~~~~~~~---~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
...+-... ..++..++.+..+++|+.+ ++|..|..+|.++...+..+....++++.
T Consensus 412 a~~~~l~~~~~~m~~~S~~f~~~~~~l~~~-~~G~~GlI~AN~iNM~lRI~ys~~fI~~~ 470 (549)
T PF04506_consen 412 ASESQLDRYNYWMVVFSAIFLAASYLLTRW-GLGAVGLILANCINMSLRIIYSLRFIRRY 470 (549)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 77665443 3344446667888999986 79999999999999999998888888765
No 37
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=98.19 E-value=0.00017 Score=65.32 Aligned_cols=200 Identities=10% Similarity=0.041 Sum_probs=145.6
Q ss_pred HHHHhHHHHHHHHHHHHHHHHHHHHHHhc---cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHH
Q 019922 53 KLWHIVGPTIFSRMASYSMFVITQAFAGH---LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLG 129 (334)
Q Consensus 53 ~~~~~~~p~~~~~~~~~~~~~i~~~~i~~---~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~ 129 (334)
+..+...-...+.++-.+.+--|.++++. +.-++.|.|.+..+.-+++.-.+...+--..-.+.+|....++.|+.+
T Consensus 240 d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~~k 319 (530)
T KOG2864|consen 240 DLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQENVK 319 (530)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhhHH
Confidence 34555566667777777778888888874 355677888888888776677778888888888888888777776666
Q ss_pred HHH---HHHHHHHHHHHHHH-HHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHH-
Q 019922 130 VYM---QRSWIVLFICCVLL-LPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA- 204 (334)
Q Consensus 130 ~~~---~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~- 204 (334)
+.. ...+.....+|+.. ..+.-.+...+.+++++.-....+...+++.+.++|+.+++.+..++..+.+..+-.-
T Consensus 320 ~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~t~~qi~~ 399 (530)
T KOG2864|consen 320 KAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVATSRQIDK 399 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhccHHHHHh
Confidence 544 45555555555333 3345566777777766554444456789999999999999999999998887665433
Q ss_pred --HHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 205 --WVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 205 --~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
+..++..+..++++|+|+. .+|..|.-+|.++-..+..+...+++++.
T Consensus 400 ~n~~mlafSviflilsylL~~--~~~~~GlIlANiiNm~lRIlys~~fI~~~ 449 (530)
T KOG2864|consen 400 HNKFMLAFSVIFLILSYLLIR--WFGLVGLILANIINMSLRILYSLRFIRHY 449 (530)
T ss_pred cccchhHHHHHHHHHHHHHHH--HhchhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3344455777889999998 47889999999998888777776666654
No 38
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=97.61 E-value=0.00047 Score=59.77 Aligned_cols=71 Identities=20% Similarity=0.136 Sum_probs=66.1
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhh
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQA 119 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~ 119 (334)
++..|++++.+.|..++.+...+...+|++++++ .|++++|.|+.+.++...+ ..+...+.+...|.++|.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ii~~~~g~~~vg~Y~~a~~l~~~~-~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 201 KKFFKEILRFGLPLFLSSLLSWLYSQIDRLIIGYFLGPEAVGIYSVAYRLASAI-SFLLSSISTVLFPRLSRL 272 (273)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhCCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHh
Confidence 6789999999999999999999999999999999 7999999999999999985 678888888999999875
No 39
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=96.79 E-value=0.01 Score=50.78 Aligned_cols=67 Identities=18% Similarity=0.134 Sum_probs=60.6
Q ss_pred HHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhh
Q 019922 53 KLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVVAFNFGLLLGMASALETLCGQA 119 (334)
Q Consensus 53 ~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~ 119 (334)
+.++.+.|..+..+.......+|.++++. +|++++|.|+.+.++...+...+..++++...|..+|.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~~~g~y~~a~~l~~~~~~~~~~~i~~~~~p~lar~ 251 (251)
T PF13440_consen 184 RLLKYGLPFSLSSLLSWLLSQIDRLLIGYFLGPEAVGIYSVAQRLASLPASLLSSAISSVFFPKLARM 251 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCC
Confidence 37999999999999999999999999999 89999999999999998753378899999999988873
No 40
>COG4267 Predicted membrane protein [Function unknown]
Probab=95.62 E-value=1.6 Score=39.33 Aligned_cols=139 Identities=13% Similarity=0.131 Sum_probs=95.4
Q ss_pred HHHHHHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhH
Q 019922 101 NFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPV 180 (334)
Q Consensus 101 ~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~ 180 (334)
...+..|++...+..+|...=++|.+++...+.-+..+....+..+... +-...++.. ..|=...+..
T Consensus 73 S~IiTgg~q~iiTRfiSD~lF~k~~~kIlpsy~Gvi~lv~~~a~~ig~~-------vf~~~~~~s-----i~yk~l~~~~ 140 (467)
T COG4267 73 SQIITGGFQLIITRFISDCLFEKKQRKILPSYIGVILLVTLVAGVIGLI-------VFFVNNQYS-----IVYKILACAL 140 (467)
T ss_pred HHHHhhhHHHHHHHHHHHHHHHHHHHHHhHhHHHHHHHHHHHHHHHHHH-------hhhhcCchh-----HHHHHHHHHH
Confidence 4455667777777888877777777777665554444443333222211 111112211 1122334455
Q ss_pred HHHHHHHHHHHHHHHHcchhhHHHHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 181 HFSFAFQFPLQRFLQSQLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 181 ~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
...+........++.+.+|.+...+.-.++.++.+.+..++-. .++.|.-++..++..+.......++.|.
T Consensus 141 FV~m~~~Wi~~iFlS~lK~y~~iv~sF~iG~~~sv~La~~~~~---~~ie~lLL~~~IGi~~i~~l~~~~Ilr~ 211 (467)
T COG4267 141 FVGMSLVWILMIFLSGLKKYKLIVLSFFIGYVVSVLLARLFLK---SPIEGLLLTLDIGIFIILFLLNFYILRY 211 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hHHHHHHHHHHHhHHHHHHHHHHHHHHh
Confidence 5666777888999999999999999999999888888877764 6999999999999999888888888776
No 41
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=95.57 E-value=2.4 Score=40.96 Aligned_cols=267 Identities=9% Similarity=-0.026 Sum_probs=128.7
Q ss_pred HhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHH-HHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHHH
Q 019922 56 HIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVV-AFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQ 133 (334)
Q Consensus 56 ~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~-~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~ 133 (334)
+-+.-.++.+++..+.+++-+.++=| ++++.+|..++=..+.. .+.+..=.++..++...-.+...++|.++..+..+
T Consensus 5 ~gas~li~lQl~sRllTFvlN~lllR~lsp~ilGi~nv~LeLl~sTILFlSRE~fR~A~lR~~~~~~~~~~~~~~~n~~w 84 (549)
T PF04506_consen 5 KGASFLILLQLLSRLLTFVLNQLLLRFLSPEILGIANVQLELLYSTILFLSREAFRRACLRQPSSSIDKSNWAQSINLLW 84 (549)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhCCHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCcccCcccHHHhhhccc
Confidence 44556778888888888887777777 89998887754443332 21233445666665543333211122223333333
Q ss_pred HHHHHHHHHHHHHHHHHH----hhHHHH--HHc-CCCHH---HHHHHHHHHHHHHhHHHHHHHHHHH----HHHHHHcch
Q 019922 134 RSWIVLFICCVLLLPLYV----FASPVL--KLL-GQPDD---VAELSGVVSLWLLPVHFSFAFQFPL----QRFLQSQLK 199 (334)
Q Consensus 134 ~~~~~~~~~~i~~~~~~~----~~~~~~--~~~-~~~~~---~~~~~~~~l~i~~~~~~~~~~~~~~----~~~l~~~g~ 199 (334)
....+..++.+++..+.+ .+..+. .+. ...++ ..+.....+.+...+...-.+..++ +..+.-.-|
T Consensus 85 ls~~lq~vvn~~~~~I~l~~igi~~~~~~~~~~~~~~~~~~~~~p~~~~~v~l~~~s~~iELlsEP~~il~Q~~l~~~~R 164 (549)
T PF04506_consen 85 LSVPLQAVVNLICSYIWLAWIGIPLSILLSQYQYASISNAFVIEPYFEPSVFLYGLSAFIELLSEPLYILAQQMLFFKLR 164 (549)
T ss_pred ccCcchhheehhHHHHhHhhccccHHHHHHHHHhhcchhhHHhhhhHHHHHHHHHHHHHHHHhhhHHHHHHHHHhhhhee
Confidence 322333333322211111 111111 111 11111 1122233334444444444444444 444444445
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHhh-ccCc-----h-hHHHHHHHHHHHHHHHHHHHHHhc---C---CCCccCCCCH-
Q 019922 200 TMVIAWVSLASLLVHLLVTWLFVYKM-QLGL-----I-GTAITLSFSWWVLIFGMFGYVACG---G---CPRTWTGFSM- 265 (334)
Q Consensus 200 ~~~~~~~~~~~~~~~i~l~~~li~~~-~~g~-----~-G~~ia~~i~~~~~~~~~~~~~~~~---~---~~~~~~~~~~- 265 (334)
.+.-.....+..+++..+........ +++. . -+.++..+++....+......... . .+....+...
T Consensus 165 v~~E~~A~~~k~i~t~~~v~~~~~~~~~~~~~~~~~~~~~~l~Falgq~~ys~~l~~~y~~~~~~~~~~~s~~lp~i~~~ 244 (549)
T PF04506_consen 165 VKAESLAVFAKCIVTFALVVLAERSGYGFFYFLSGQEGLAILAFALGQLAYSITLFFCYYWMYFFPFKSFSDLLPKISSG 244 (549)
T ss_pred eEechHHHHHHHHHHHHHHHHHHhcccceeeeeccchhHHHHHHHHHHHHHHHHHHhhHHhhccCcccchhhcccccccc
Confidence 55555555555555444433332210 1111 1 123455555554443332222111 1 1111111111
Q ss_pred --HhHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc--CCchhhHHHHHHHHHHHHHHHH
Q 019922 266 --EAFSDLWEFVKLSVASGVMLCLENWYYRVLILMTGN--LQNAKIAVDALSICMSINGWEL 323 (334)
Q Consensus 266 --~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~aa~~i~~~i~~~~~ 323 (334)
+....-++++++......+.+...+..+-...+++. +.+.+ +.|.|.+++|+.+++-
T Consensus 245 ~~~~~~fd~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~-~QGvY~lv~N~GSLva 305 (549)
T PF04506_consen 245 NPKSYYFDRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFE-DQGVYALVSNYGSLVA 305 (549)
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHH-HhhHHHHHhhHHHHHH
Confidence 011124678888888888888899888888888888 55432 5679999999988763
No 42
>PF02487 CLN3: CLN3 protein; InterPro: IPR003492 Batten's disease, the juvenile variant of neuronal ceroid lipofuscionosis (NCL), is a recessively inherited disorder affecting children of 5-10 years of age. The disease is characterised by progressive loss of vision, seizures and psychomotor disturbances. Biochemically, the disease is characterised by lysosomal accumulation of hydrophobic material, mainly ATP synthase subunit C, largely in the brain but also in other tissues. The disease is fatal within a decade []. Mutations in the CLN3 gene are believed to cause Batten's disease []. The CLN3 gene, with a predicted 438-residue product, maps to chromosome p16p12.1. The gene contains at least 15 exons spanning 15kb and is highly conserved in mammals []. A 1.02kb deletion in the CLN3 gene, occurring in either one or both alleles, is found in 85% of Batten disease chromosomes causing a frameshift generating a predicted translated product of 181 amino acid residues [, ]. 22 other mutations, including deletions, insertions and point mutations, have been reported. It has been suggested that such mutations result in severely truncated CLN3 proteins, or affect its structure/conformation [, ]. CLN3 proteins, which are believed to associate in complexes, are heavily glycosylated lysosomal membrane proteins [], containing complex Asn-linked oligosaccharides []. Extensive glycosylation is important for the stability of these lysosomal proteins in the highly hydrolytic lysosomal lumen. Lysosomal sequestration of active lysosomal enzymes, transport of degraded molecules from the lysosomes, and fusion and fission between lysosomes and other organelles. The CLN3 protein is a 43kDa, highly hydrophobic, multi-transmembrane (TM), phosphorylated protein []. Hydrophobicity analysis predicts 6-9 TM segments, suggesting that CLN3 is a TM protein that may function as a chaperone or signal transducer. The majority of putative phosphorylation sites are found in the N-terminal domain, encompassing 150 residues []. Phosphorylation is believed to be important for membrane compartment interaction, in the formation of functional complexes, and in regulation and interactions with other proteins []. CLN3 contains several motifs that may undergo lipid post-translational modifications (PTMs). PTMs contribute to targeting and anchoring of modified proteins to distinct biological membranes []. There are three general classes of lipid modification: N-terminal myristoylation, C-terminal prenylation, and palmitoylation of cysteine residues. Such modifications are believed to be a common form of PTM occurring in 0.5% of all cellular proteins, including brain tissue []. The C terminus of the CLN3 contains various lipid modification sites: C435, target for prenylation; G419, target for myristoylation; and C414, target for palmitoylation []. Prenylation results in protein hydrophobicity, influences interaction with upstream regulatory proteins and downstream effectors, facilitates protein-protein interaction (multisubunit assembly) and promotes anchoring to membrane lipids. The prenylation motif, Cys-A-A-X, is highly conserved within CLN3 protein sequences of different species []. Species with known CLN3 protein homologues include: Homo sapiens, Canis familiaris, Mus musculus, Saccharomyces cerevisiae and Drosophila melanogaster.; GO: 0016020 membrane
Probab=74.67 E-value=13 Score=34.41 Aligned_cols=29 Identities=17% Similarity=0.114 Sum_probs=22.3
Q ss_pred hHHHHHHHHHHHHhHHHHHHHHHHHHHHH
Q 019922 44 TRRFWIESKKLWHIVGPTIFSRMASYSMF 72 (334)
Q Consensus 44 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 72 (334)
.+...+..|.++++.+|..+..+.+.+.+
T Consensus 235 ~~~k~~~~k~Ll~ymiPL~lVY~aEY~In 263 (402)
T PF02487_consen 235 FKEKLKRLKPLLWYMIPLFLVYFAEYFIN 263 (402)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34455678888889999999999887653
No 43
>COG4267 Predicted membrane protein [Function unknown]
Probab=73.48 E-value=75 Score=29.18 Aligned_cols=116 Identities=10% Similarity=0.063 Sum_probs=66.4
Q ss_pred hhHHHHHHHHHHHHHHHHHHH-HHHHHhhHHHHHHcCCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHH
Q 019922 126 YMLGVYMQRSWIVLFICCVLL-LPLYVFASPVLKLLGQPDDVAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIA 204 (334)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 204 (334)
++.....++.+.-..-+-... ..++..++.+..+++-++-.. +.+++-.++...+.....+-...-=.++.+..+
T Consensus 320 ~kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~~~l----~lF~vd~lg~s~~i~f~~ll~i~lyfd~r~i~l 395 (467)
T COG4267 320 KKMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSEYYL----DLFYVDVLGVSCQIVFMSLLNIFLYFDYRRIAL 395 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 334444444444444443333 344557888888887665433 345666666555544444444444456677788
Q ss_pred HHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHH
Q 019922 205 WVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMF 248 (334)
Q Consensus 205 ~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~ 248 (334)
..+..-...|-++.++... +|..--..+..++..+..++..
T Consensus 396 ~~t~~fli~N~ilT~i~l~---lgp~~~g~gff~a~fl~vlv~~ 436 (467)
T COG4267 396 ELTALFLISNGILTFIFLE---LGPGYYGVGFFLASFLYVLVAF 436 (467)
T ss_pred hhhhHHHHHhHHHHHHHHH---hCccceehHHHHHHHHHHHHHH
Confidence 8888888899999888885 3433333344444444444433
No 44
>TIGR00927 2A1904 K+-dependent Na+/Ca+ exchanger.
Probab=67.35 E-value=10 Score=38.81 Aligned_cols=34 Identities=9% Similarity=-0.189 Sum_probs=14.5
Q ss_pred HHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHH
Q 019922 116 CGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPL 149 (334)
Q Consensus 116 ~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 149 (334)
.+...|.+|..-....-...+-+.+.++++..+.
T Consensus 989 ivArkG~gdMAVan~iGSNIFnIllgLGlPWlI~ 1022 (1096)
T TIGR00927 989 IVARKGLGDMAVSSSVGSNIFDITVGLPVPWLLF 1022 (1096)
T ss_pred HHHHccCCcceeeeccccchheeeeeccHHHHHH
Confidence 3333454444333333334444444555554443
No 45
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=61.34 E-value=1.5e+02 Score=28.08 Aligned_cols=49 Identities=8% Similarity=-0.019 Sum_probs=33.8
Q ss_pred HHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHH
Q 019922 50 ESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELAAISIANTVVV 98 (334)
Q Consensus 50 ~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a~~~i~~~~~~ 98 (334)
....-.+-+.-.+..+++..+.++.-+.++=| ++++.+|..++=..+.+
T Consensus 6 vL~ss~~ga~~~i~~Q~~~RiiTF~lN~~liR~~s~~v~gi~nvrl~lL~ 55 (530)
T KOG2864|consen 6 VLESSFSGAVFSIRGQLLARIITFALNALLIRFLSPEVLGIVNVRLELLQ 55 (530)
T ss_pred HHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHcChhheehhHHHHHHHH
Confidence 34445566666777777777777766555555 89999998877665554
No 46
>KOG3880 consensus Predicted small molecule transporter involved in cellular pH homeostasis (Batten disease protein in human) [General function prediction only]
Probab=56.48 E-value=52 Score=29.51 Aligned_cols=33 Identities=15% Similarity=0.049 Sum_probs=24.7
Q ss_pred hhhhHHHHHHHHHHHHhHHHHHHHHHHHHHHHH
Q 019922 41 GTLTRRFWIESKKLWHIVGPTIFSRMASYSMFV 73 (334)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 73 (334)
+.-.++..+..|.++++.+|.....+.+...+.
T Consensus 236 ~~~~~e~~~~i~pll~~MvPL~~VY~~EY~INQ 268 (409)
T KOG3880|consen 236 RLGLKETLKRIKPLLKYMVPLALVYFAEYFINQ 268 (409)
T ss_pred hhcHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 334556677888999999999988887766543
No 47
>PF11947 DUF3464: Protein of unknown function (DUF3464); InterPro: IPR021855 This family of proteins are functionally uncharacterised. This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 137 to 196 amino acids in length.
Probab=48.24 E-value=1.4e+02 Score=23.63 Aligned_cols=25 Identities=8% Similarity=0.033 Sum_probs=16.6
Q ss_pred HHHHHHHhHHHHHHHHHHHHHHHHH
Q 019922 50 ESKKLWHIVGPTIFSRMASYSMFVI 74 (334)
Q Consensus 50 ~~~~~~~~~~p~~~~~~~~~~~~~i 74 (334)
.-|-.+..++|+.++.....+...+
T Consensus 62 ~rRm~~~~GiP~~lG~~~f~~~y~l 86 (153)
T PF11947_consen 62 LRRMAVFVGIPTALGVAVFVVFYYL 86 (153)
T ss_pred HHHHHHHhchHHHHHHHHHHHHHHH
Confidence 3445577788888887766655544
No 48
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=45.88 E-value=34 Score=25.83 Aligned_cols=27 Identities=11% Similarity=-0.032 Sum_probs=13.7
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhcC
Q 019922 229 LIGTAITLSFSWWVLIFGMFGYVACGG 255 (334)
Q Consensus 229 ~~G~~ia~~i~~~~~~~~~~~~~~~~~ 255 (334)
+.|..++.+++-+...+++.|+++|++
T Consensus 66 i~~Ii~gv~aGvIg~Illi~y~irR~~ 92 (122)
T PF01102_consen 66 IIGIIFGVMAGVIGIILLISYCIRRLR 92 (122)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred eeehhHHHHHHHHHHHHHHHHHHHHHh
Confidence 445555555555444445555555543
No 49
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=42.65 E-value=1.1e+02 Score=21.12 Aligned_cols=33 Identities=6% Similarity=-0.016 Sum_probs=24.9
Q ss_pred HHHHhhhccCchhhHHHHHHHHHHHHHHHHHHH
Q 019922 114 TLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLL 146 (334)
Q Consensus 114 ~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~ 146 (334)
..+-..+.+||++++++.-+++..++.+..+..
T Consensus 42 ~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~~g 74 (82)
T PF04505_consen 42 SKVRSRYAAGDYEGARRASRKAKKWSIIAIIIG 74 (82)
T ss_pred hhhHHHHHCCCHHHHHHHHHHhHHHHHHHHHHH
Confidence 556677888999999999888887776555433
No 50
>PLN03100 Permease subunit of ER-derived-lipid transporter; Provisional
Probab=42.24 E-value=2.5e+02 Score=24.91 Aligned_cols=19 Identities=11% Similarity=0.036 Sum_probs=11.0
Q ss_pred ccCchhHHHHHHHHHHHHH
Q 019922 226 QLGLIGTAITLSFSWWVLI 244 (334)
Q Consensus 226 ~~g~~G~~ia~~i~~~~~~ 244 (334)
+-|..|+.-++.-+-..+.
T Consensus 257 ~gGa~gVG~Att~aVV~s~ 275 (292)
T PLN03100 257 TGGAKGVGESTTSAVVISL 275 (292)
T ss_pred CCCccHHHHHHHHHHHHHH
Confidence 4566666666665554443
No 51
>PRK03612 spermidine synthase; Provisional
Probab=40.40 E-value=3.5e+02 Score=26.17 Aligned_cols=49 Identities=24% Similarity=0.190 Sum_probs=29.1
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHhhccCchhHHHHHHHHHHHHHHHHHHHH
Q 019922 201 MVIAWVSLASLLVHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIFGMFGYV 251 (334)
Q Consensus 201 ~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~~~~~~~ 251 (334)
+.....++.+.+-.+...++++. .+|..+..+....-++...++..+..
T Consensus 149 ~ly~~ntlGa~~G~l~~~~vLlp--~lG~~~t~~~~a~l~~~~a~~~~~~~ 197 (521)
T PRK03612 149 TVLAADYLGALVGGLAFPFLLLP--RLGLIRTAALTGSLNLLAALVFLWLF 197 (521)
T ss_pred hhHhHHhHHHHHHHHHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 44555555555555666777776 57887777666666655554443333
No 52
>PF03904 DUF334: Domain of unknown function (DUF334); InterPro: IPR005602 This is a family of proteins found in Staphylococcus aureus plasmid with no characterised function.
Probab=38.77 E-value=2.2e+02 Score=24.03 Aligned_cols=39 Identities=15% Similarity=0.180 Sum_probs=20.2
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCC
Q 019922 124 KYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQ 162 (334)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 162 (334)
+++...+.+..++...+.+-+++++++.+..++..+++.
T Consensus 142 ~y~k~~k~~~~gi~aml~Vf~LF~lvmt~g~d~m~fl~v 180 (230)
T PF03904_consen 142 KYQKRQKSMYKGIGAMLFVFMLFALVMTIGSDFMDFLHV 180 (230)
T ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHhcccchhhhhH
Confidence 344444444444444444444445555566676666653
No 53
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=36.90 E-value=1.7e+02 Score=26.34 Aligned_cols=61 Identities=7% Similarity=0.106 Sum_probs=47.5
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchh-hHHHHHHHHHHHHHHHHHHHHhh
Q 019922 269 SDLWEFVKLSVASGVMLCLENWYYRVLILMTGNLQNAK-IAVDALSICMSINGWELMIPLSF 329 (334)
Q Consensus 269 ~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~g~~~-~~~aa~~i~~~i~~~~~~~~~~~ 329 (334)
.+++++++.-+|.+++..+..+.-.+.+.-+++-.+.+ ..+|+|+++..+.-+.-.+...+
T Consensus 8 ~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~~sp~~~~ 69 (345)
T PF07260_consen 8 TSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFFASPLSMF 69 (345)
T ss_pred chHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHHhChhhhh
Confidence 46889999999999999988888888888888754333 34789999998887776654443
No 54
>KOG2234 consensus Predicted UDP-galactose transporter [Carbohydrate transport and metabolism]
Probab=36.58 E-value=3.3e+02 Score=24.72 Aligned_cols=52 Identities=12% Similarity=0.020 Sum_probs=29.0
Q ss_pred HHHHHHHHHHHHHHHHHhc-CC--CCccCCCCHHhHhhHHHHHHHHHHHHHHHHH
Q 019922 236 LSFSWWVLIFGMFGYVACG-GC--PRTWTGFSMEAFSDLWEFVKLSVASGVMLCL 287 (334)
Q Consensus 236 ~~i~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~ 287 (334)
...++++-.++....+.++ +. ++..+...+..+...++.+|.++|.++-..-
T Consensus 51 v~~~Ei~Kl~~c~~~~~~~~~~~~~~~~~~l~~~i~~~~~~~lk~~vPa~iYalq 105 (345)
T KOG2234|consen 51 VFLTEVIKLVFCLFLLLFEERKYAKKSLKSLSKEILAAPRETLKVSVPALIYALQ 105 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHhhhhhhhcCHHHHhChHHHHHHHHHHHHHHHh
Confidence 3344444444444444433 11 2333345556667788999999998874443
No 55
>PF05313 Pox_P21: Poxvirus P21 membrane protein; InterPro: IPR007977 The p21 membrane protein of vaccinia virus, encoded by the A17L (or A18L) gene, has been reported to localise on the inner of the two membranes of the intracellular mature virus (IMV). It has also been shown that p21 acts as a membrane anchor for the externally located fusion protein P14 (A27L gene) [].; GO: 0016021 integral to membrane
Probab=35.37 E-value=2.4e+02 Score=22.84 Aligned_cols=27 Identities=15% Similarity=0.141 Sum_probs=20.4
Q ss_pred CchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 228 GLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 228 g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
+..|-..++.+.+++.+++...|..+.
T Consensus 135 ~~s~s~~~~ti~yIiL~iLf~~Ya~nl 161 (189)
T PF05313_consen 135 SVSGSSGAYTISYIILAILFCIYAFNL 161 (189)
T ss_pred hhhHhHHHHHHHHHHHHHHHHHheeec
Confidence 344777888888888888877777665
No 56
>KOG0569 consensus Permease of the major facilitator superfamily [Carbohydrate transport and metabolism]
Probab=35.24 E-value=4.1e+02 Score=25.48 Aligned_cols=34 Identities=15% Similarity=0.246 Sum_probs=20.0
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHHHHHhhccCchhH
Q 019922 197 QLKTMVIAWVSLASLLVHLLVTWLFVYKMQLGLIGT 232 (334)
Q Consensus 197 ~g~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~ 232 (334)
.-|+....+...+.-+.|.+..+.+... ....|.
T Consensus 400 ~~R~aa~s~~~~~~w~~~fiv~~~fp~l--~~~~g~ 433 (485)
T KOG0569|consen 400 SARSAAQSVATAVNWLSNFIVGFAFPPL--QNVIGP 433 (485)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHHH--HHHhcc
Confidence 3455555566666667777777766663 344554
No 57
>PF14184 YrvL: Regulatory protein YrvL
Probab=31.65 E-value=2.4e+02 Score=21.63 Aligned_cols=110 Identities=14% Similarity=0.144 Sum_probs=62.5
Q ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHH-HHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcchhhHHHHHHHHHHH
Q 019922 134 RSWIVLFICCVLLLPLYVFASPVLKLLGQPDD-VAELSGVVSLWLLPVHFSFAFQFPLQRFLQSQLKTMVIAWVSLASLL 212 (334)
Q Consensus 134 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~ 212 (334)
......+.+.+..+...+....+++++|.+-+ ......-.+-...++.|+......+...+.-.+-++.... .....
T Consensus 6 ~~i~~~l~~~~v~a~~ff~~~gif~L~Gi~Y~S~~~llLF~li~~~lg~~~e~~~k~l~~~l~~~~~~~~~~~--~l~~~ 83 (132)
T PF14184_consen 6 IFIIIALLLIIVFAIYFFVMVGIFHLLGIEYESVGSLLLFFLIIFVLGLPFELFEKVLLKALLFLRMSRRLFI--LLAFI 83 (132)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhCcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCchHHHH--HHHHH
Confidence 33444444445555555566777788765432 2233333445566677777777776666665533333332 23346
Q ss_pred HHHHHHHHHHHhhccCchhHHHHHHHHHHHHHH
Q 019922 213 VHLLVTWLFVYKMQLGLIGTAITLSFSWWVLIF 245 (334)
Q Consensus 213 ~~i~l~~~li~~~~~g~~G~~ia~~i~~~~~~~ 245 (334)
+...++|..++..+.=+.++.+.+..--+++.+
T Consensus 84 id~~~t~~~i~~aD~~m~sI~is~~~e~i~al~ 116 (132)
T PF14184_consen 84 IDFLFTWITIYTADELMESISISTLSEIIFALL 116 (132)
T ss_pred HHHHHHHHHHHHHHHHhcceeeCcHHHHHHHHH
Confidence 677888888876655566666666554444443
No 58
>PF05393 Hum_adeno_E3A: Human adenovirus early E3A glycoprotein; InterPro: IPR008652 This family consists of several early glycoproteins (E3A), from human adenovirus type 2.; GO: 0016021 integral to membrane
Probab=30.70 E-value=1e+02 Score=21.65 Aligned_cols=29 Identities=7% Similarity=0.047 Sum_probs=20.2
Q ss_pred ccCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 226 QLGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 226 ~~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
++.-.|.++..++..++..+++++.++++
T Consensus 29 ~~~~Lgm~~lvI~~iFil~VilwfvCC~k 57 (94)
T PF05393_consen 29 NWPNLGMWFLVICGIFILLVILWFVCCKK 57 (94)
T ss_pred CCCccchhHHHHHHHHHHHHHHHHHHHHH
Confidence 44455677888888877777777666654
No 59
>TIGR00383 corA magnesium Mg(2+) and cobalt Co(2+) transport protein (corA). The article in Microb Comp Genomics 1998;3(3):151-69 (Medline:98448512) discusses this family and suggests that some members may have functions other than Mg2+ transport.
Probab=30.54 E-value=3.1e+02 Score=24.27 Aligned_cols=27 Identities=11% Similarity=0.080 Sum_probs=11.7
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHh
Q 019922 198 LKTMVIAWVSLASLLVHLLVTWLFVYK 224 (334)
Q Consensus 198 g~~~~~~~~~~~~~~~~i~l~~~li~~ 224 (334)
+..+..-..++++.++-.+--...++|
T Consensus 253 ~~N~~mk~LTvvt~IflP~t~IaGiyG 279 (318)
T TIGR00383 253 KMNEIMKILTVVSTIFIPLTFIAGIYG 279 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 334444455555554433333333343
No 60
>PF03303 WTF: WTF protein; InterPro: IPR004982 This is a family of mainly hypothetical Schizosacchoromyces pombe proteins that are often encoded near long terminal repeats within the genome. Their function is unknown but they contain several predicted transmembrane regions and at least one protein is up-regulated during meiosis []. Upregulation is also observed in histone deacetylase mutants, indicating their transcription is normally inhibited by hypoacetylation [].
Probab=29.34 E-value=3.5e+02 Score=22.90 Aligned_cols=42 Identities=17% Similarity=0.067 Sum_probs=22.6
Q ss_pred HHHHHHhHHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHH
Q 019922 51 SKKLWHIVGPTIFSRMASYSMFVITQAFAGHLGDLELAAISI 92 (334)
Q Consensus 51 ~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~a~~~i 92 (334)
..+++..-.|...-++....+......+.+.+|..+=-.+|+
T Consensus 88 l~kl~is~~~v~v~n~~~~c~l~~k~a~F~~~~~~ewvlfG~ 129 (247)
T PF03303_consen 88 LLKLLISFLPVSVFNFVAVCYLPYKDASFKDYGFMEWVLFGI 129 (247)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 334444445555555555666666666666666553333343
No 61
>PF08627 CRT-like: CRT-like; InterPro: IPR013936 This region is found in proteins related to Plasmodium falciparum chloroquine resistance transporter (CRT).
Probab=28.49 E-value=2.7e+02 Score=21.18 Aligned_cols=28 Identities=7% Similarity=-0.185 Sum_probs=18.2
Q ss_pred HHHhHHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 54 LWHIVGPTIFSRMASYSMFVITQAFAGH 81 (334)
Q Consensus 54 ~~~~~~p~~~~~~~~~~~~~i~~~~i~~ 81 (334)
+-|-++++.+..++..+...+++.+.-+
T Consensus 51 ~~ke~~~L~v~~vv~V~s~v~N~VL~K~ 78 (130)
T PF08627_consen 51 YSKENFKLLVYVVVYVVSGVINRVLYKK 78 (130)
T ss_pred hhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 3456667777777777777776666554
No 62
>PRK10739 putative antibiotic transporter; Provisional
Probab=28.05 E-value=3.5e+02 Score=22.37 Aligned_cols=64 Identities=11% Similarity=0.166 Sum_probs=39.4
Q ss_pred HHHHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHH
Q 019922 103 GLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSG 171 (334)
Q Consensus 103 ~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (334)
.+...++.. |..-..-...++++.++..++....+..+ +.+..++.+.+++.|+-+-+..+.+.
T Consensus 13 ~iinPig~i--piflslt~~~~~~~r~~ia~~a~~~a~~i---ll~f~~~G~~iL~~fGIsl~afrIAG 76 (197)
T PRK10739 13 LIMDPLGNL--PIFMSVLKHLEPKRRRAIMIRELLIALLV---MLVFLFAGEKILAFLNLRTETVSISG 76 (197)
T ss_pred HHHhHhhHH--HHHHHHhCCCCHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHhCCCHHHHHHHH
Confidence 344555554 66665555566677777666555444433 33455678899999988766555544
No 63
>COG4956 Integral membrane protein (PIN domain superfamily) [General function prediction only]
Probab=27.45 E-value=4.5e+02 Score=23.51 Aligned_cols=33 Identities=9% Similarity=-0.155 Sum_probs=21.2
Q ss_pred HHHHHHHHHhHHHHHHhhhccCchhhHHHHHHH
Q 019922 102 FGLLLGMASALETLCGQAFGGKKYYMLGVYMQR 134 (334)
Q Consensus 102 ~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~ 134 (334)
..++.++|....|-+-...|-+|..-.+..+..
T Consensus 11 ~i~g~~lG~~~~p~ll~~~~~~~~~~~~n~~v~ 43 (356)
T COG4956 11 IIIGAVLGFAVIPELLADLGIQDTAFLNNEYVD 43 (356)
T ss_pred HHHHhhhhHhhHHHHHhhcCcccchhhccHHHH
Confidence 445666777777777777777666555544444
No 64
>TIGR00893 2A0114 d-galactonate transporter.
Probab=25.75 E-value=4.6e+02 Score=23.06 Aligned_cols=18 Identities=6% Similarity=-0.023 Sum_probs=7.2
Q ss_pred hhhHHHHHHHHHHHHHHH
Q 019922 199 KTMVIAWVSLASLLVHLL 216 (334)
Q Consensus 199 ~~~~~~~~~~~~~~~~i~ 216 (334)
+.+.....+....+.+.+
T Consensus 345 ~g~~~~~~~~~~~~g~~~ 362 (399)
T TIGR00893 345 AGLTGGLINSLGNLGGIV 362 (399)
T ss_pred HHHHHHHHHHHHHHhhhh
Confidence 334444444444333333
No 65
>PRK11085 magnesium/nickel/cobalt transporter CorA; Provisional
Probab=25.71 E-value=3.5e+02 Score=24.24 Aligned_cols=12 Identities=8% Similarity=-0.017 Sum_probs=6.1
Q ss_pred HHHHHHHHHHhc
Q 019922 243 LIFGMFGYVACG 254 (334)
Q Consensus 243 ~~~~~~~~~~~~ 254 (334)
..+..+++++|+
T Consensus 302 ~~~~~~~~f~rk 313 (316)
T PRK11085 302 AGLAPYLYFKRK 313 (316)
T ss_pred HHHHHHHHHHHc
Confidence 344455566554
No 66
>KOG0637 consensus Sucrose transporter and related proteins [Carbohydrate transport and metabolism]
Probab=25.13 E-value=3.1e+02 Score=26.18 Aligned_cols=73 Identities=12% Similarity=0.091 Sum_probs=43.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHHHH-hhHHHHHHcCCCHHH
Q 019922 90 ISIANTVVVAFNFGLLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPLYV-FASPVLKLLGQPDDV 166 (334)
Q Consensus 90 ~~i~~~~~~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~ 166 (334)
.++--.+.+++ ....--.+.-++|+++.+ .|+-+.|---++-......+.+.+.+.++ ++.++-..++++++.
T Consensus 62 lGvphk~~S~i-w~~gPi~G~~vQP~vG~~---SDrc~sr~GRRRPfI~~~s~~i~~~l~Lig~aaDig~~lgd~~~~ 135 (498)
T KOG0637|consen 62 LGVPHKWSSII-WLCGPLSGLLVQPLVGSA---SDRCTSRYGRRRPFILAGSLLIAVSLFLIGYAADIGLLLGDNERK 135 (498)
T ss_pred cCCCccccccc-ccccccccceeccccccc---ccccccccccccchHHHhhHHHHHHHhhhhhHhhhhHHhcCCccc
Confidence 33334444442 334444555667887765 45555554555666666666666666544 888888888877654
No 67
>PRK11111 hypothetical protein; Provisional
Probab=25.07 E-value=4.1e+02 Score=22.24 Aligned_cols=62 Identities=11% Similarity=0.055 Sum_probs=35.1
Q ss_pred HHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHH
Q 019922 105 LLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSG 171 (334)
Q Consensus 105 ~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (334)
...++.. |..-..-...++++.++..++...... +.+.+..++.++++..|+-+-+..+.+.
T Consensus 21 inPig~i--piflslt~~~s~~~r~~ia~~a~l~a~---~ill~f~~~G~~iL~~fGIsl~afrIaG 82 (214)
T PRK11111 21 VNPVGIL--PVFISMTSHQTAAERNKTNLTANLSVA---IILLISLFLGDFILNLFGISIDSFRIAG 82 (214)
T ss_pred hCcchhH--HHHHHHhCCCCHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHHhCCCHHHHHHHH
Confidence 3444443 555444444455556655555443333 3334456678899999988766555444
No 68
>PF01914 MarC: MarC family integral membrane protein; InterPro: IPR002771 Members of this family are integral membrane proteins that includes the antibiotic resistance protein MarC. These proteins may be transporters. ; GO: 0016021 integral to membrane
Probab=23.81 E-value=4.2e+02 Score=21.91 Aligned_cols=63 Identities=17% Similarity=0.237 Sum_probs=36.8
Q ss_pred HHHHHHHhHHHHHHhhhccCchhhHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHcCCCHHHHHHHH
Q 019922 104 LLLGMASALETLCGQAFGGKKYYMLGVYMQRSWIVLFICCVLLLPLYVFASPVLKLLGQPDDVAELSG 171 (334)
Q Consensus 104 ~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (334)
+...++.. |..-..-+..++++.++..++....+.+ .+.+..++.+.+++.|+-+-+..+.+.
T Consensus 14 iinP~g~i--p~f~~lt~~~~~~~r~~ia~~a~~~a~~---ill~f~~~G~~iL~~fgIsl~af~IaG 76 (203)
T PF01914_consen 14 IINPIGNI--PIFLSLTKGMSPKERRRIARRASIIAFI---ILLIFAFFGQLILNFFGISLPAFRIAG 76 (203)
T ss_pred HHhHHHHH--HHHHHHhCCCCHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHhCCCHHHHHHHH
Confidence 34444444 5555555555666666666655444433 334445578889999987766555443
No 69
>PF05975 EcsB: Bacterial ABC transporter protein EcsB; InterPro: IPR010288 ABC transporters belong to the ATP-Binding Cassette (ABC) superfamily, which uses the hydrolysis of ATP to energise diverse biological systems. ABC transporters minimally consist of two conserved regions: a highly conserved ATP binding cassette (ABC) and a less conserved transmembrane domain (TMD). These can be found on the same protein or on two different ones. Most ABC transporters function as a dimer and therefore are constituted of four domains, two ABC modules and two TMDs. ABC transporters are involved in the export or import of a wide variety of substrates ranging from small ions to macromolecules. The major function of ABC import systems is to provide essential nutrients to bacteria. They are found only in prokaryotes and their four constitutive domains are usually encoded by independent polypeptides (two ABC proteins and two TMD proteins). Prokaryotic importers require additional extracytoplasmic binding proteins (one or more per systems) for function. In contrast, export systems are involved in the extrusion of noxious substances, the export of extracellular toxins and the targeting of membrane components. They are found in all living organisms and in general the TMD is fused to the ABC module in a variety of combinations. Some eukaryotic exporters encode the four domains on the same polypeptide chain []. The ABC module (approximately two hundred amino acid residues) is known to bind and hydrolyse ATP, thereby coupling transport to ATP hydrolysis in a large number of biological processes. The cassette is duplicated in several subfamilies. Its primary sequence is highly conserved, displaying a typical phosphate-binding loop: Walker A, and a magnesium binding site: Walker B. Besides these two regions, three other conserved motifs are present in the ABC cassette: the switch region which contains a histidine loop, postulated to polarise the attaching water molecule for hydrolysis, the signature conserved motif (LSGGQ) specific to the ABC transporter, and the Q-motif (between Walker A and the signature), which interacts with the gamma phosphate through a water bond. The Walker A, Walker B, Q-loop and switch region form the nucleotide binding site [, , ]. The 3D structure of a monomeric ABC module adopts a stubby L-shape with two distinct arms. ArmI (mainly beta-strand) contains Walker A and Walker B. The important residues for ATP hydrolysis and/or binding are located in the P-loop. The ATP-binding pocket is located at the extremity of armI. The perpendicular armII contains mostly the alpha helical subdomain with the signature motif. It only seems to be required for structural integrity of the ABC module. ArmII is in direct contact with the TMD. The hinge between armI and armII contains both the histidine loop and the Q-loop, making contact with the gamma phosphate of the ATP molecule. ATP hydrolysis leads to a conformational change that could facilitate ADP release. In the dimer the two ABC cassettes contact each other through hydrophobic interactions at the antiparallel beta-sheet of armI by a two-fold axis [, , , , , ]. The ATP-Binding Cassette (ABC) superfamily forms one of the largest of all protein families with a diversity of physiological functions []. Several studies have shown that there is a correlation between the functional characterisation and the phylogenetic classification of the ABC cassette [, ]. More than 50 subfamilies have been described based on a phylogenetic and functional classification [, , ]; (for further information see http://www.tcdb.org/tcdb/index.php?tc=3.A.1). This family consists of several bacterial ABC transporter proteins which are homologous to the EcsB protein of Bacillus subtilis. EcsB is thought to encode a hydrophobic protein with six membrane-spanning helices in a pattern found in other hydrophobic components of ABC transporters [].
Probab=22.69 E-value=6.1e+02 Score=23.34 Aligned_cols=35 Identities=23% Similarity=0.411 Sum_probs=26.9
Q ss_pred chhhHHHHHHHHHHHHHHHHHHH-HHHHHhhHHHHH
Q 019922 124 KYYMLGVYMQRSWIVLFICCVLL-LPLYVFASPVLK 158 (334)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 158 (334)
++++.+++.+++...+....... .++....-|+..
T Consensus 89 ~e~~~~~y~~~a~~yS~~~~~~~~~~~~~ll~Pl~~ 124 (386)
T PF05975_consen 89 KESEMKQYFKRALRYSFVLQLLIQLLVFLLLLPLLM 124 (386)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 46789999999999999998554 444556667665
No 70
>PTZ00370 STEVOR; Provisional
Probab=21.88 E-value=1.4e+02 Score=26.16 Aligned_cols=28 Identities=11% Similarity=0.065 Sum_probs=19.5
Q ss_pred cCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 227 LGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 227 ~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
++..|.+.-..+.-.+.+++++++++|+
T Consensus 254 F~Pygiaalvllil~vvliilYiwlyrr 281 (296)
T PTZ00370 254 FYPYGIAALVLLILAVVLIILYIWLYRR 281 (296)
T ss_pred hcccHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3556666666777777777777777765
No 71
>TIGR01478 STEVOR variant surface antigen, stevor family. This model represents the stevor branch of the rifin/stevor family (pfam02009) of predicted variant surface antigens as found in Plasmodium falciparum. This model is based on a set of stevor sequences kindly provided by Matt Berriman from the Sanger Center. This is a global model and assesses a penalty for incomplete sequence. Additional fragmentary sequences may be found with the fragment model and a cutoff of 8 bits.
Probab=21.41 E-value=1.3e+02 Score=26.25 Aligned_cols=28 Identities=11% Similarity=0.050 Sum_probs=19.8
Q ss_pred cCchhHHHHHHHHHHHHHHHHHHHHHhc
Q 019922 227 LGLIGTAITLSFSWWVLIFGMFGYVACG 254 (334)
Q Consensus 227 ~g~~G~~ia~~i~~~~~~~~~~~~~~~~ 254 (334)
+...|.+.-..+.-.+.+++++++++|+
T Consensus 258 F~Pcgiaalvllil~vvliiLYiWlyrr 285 (295)
T TIGR01478 258 FLPYGIAALVLIILTVVLIILYIWLYRR 285 (295)
T ss_pred hcccHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 4556777777777777777787787765
No 72
>TIGR00939 2a57 Equilibrative Nucleoside Transporter (ENT).
Probab=20.52 E-value=2e+02 Score=27.05 Aligned_cols=25 Identities=12% Similarity=0.065 Sum_probs=14.7
Q ss_pred HHHHHHHHhHHHHHHHHHHHHHHHH
Q 019922 49 IESKKLWHIVGPTIFSRMASYSMFV 73 (334)
Q Consensus 49 ~~~~~~~~~~~p~~~~~~~~~~~~~ 73 (334)
...++++|-.+|..+...+....++
T Consensus 262 ~~~~~v~kki~~~~~~vf~~F~vTL 286 (437)
T TIGR00939 262 TSVWVVFTKVWLLAFSVVFVFTVTL 286 (437)
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3455566666777666665555444
No 73
>COG4176 ProW ABC-type proline/glycine betaine transport system, permease component [Amino acid transport and metabolism]
Probab=20.27 E-value=5.2e+02 Score=22.64 Aligned_cols=41 Identities=17% Similarity=0.152 Sum_probs=29.5
Q ss_pred HHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHhc-cChhHHH
Q 019922 48 WIESKKLWHIVGPTIFSRMASYSMFVITQAFAGH-LGDLELA 88 (334)
Q Consensus 48 ~~~~~~~~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~a 88 (334)
...+|--+-++.|.++..+=+.++..+.+..++. .|...++
T Consensus 199 Q~L~kVqLPlA~PtIMaGiNQtIMlALsMVVIAsMIGa~GLG 240 (290)
T COG4176 199 QKLFKVQLPLALPTIMAGINQTIMLALSMVVIASMIGAGGLG 240 (290)
T ss_pred HHHHHhcCcccHHHHHHhhHHHHHHHHHHHHHHHHHcCCCCc
Confidence 4556666777888888888888888877777776 5665554
Done!